Gene to GO BP test for over-representation
| GOBPID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0035556 | 0.00000 | 2.57344 | 39 | 85 | 2571 | intracellular signal transduction |
| GO:0032502 | 0.00000 | 2.14785 | 93 | 153 | 6097 | developmental process |
| GO:0048731 | 0.00000 | 2.14760 | 71 | 123 | 4638 | system development |
| GO:0016043 | 0.00000 | 2.05578 | 91 | 146 | 5929 | cellular component organization |
| GO:0032879 | 0.00000 | 2.38054 | 42 | 85 | 2749 | regulation of localization |
| GO:0065008 | 0.00000 | 2.18433 | 61 | 109 | 3955 | regulation of biological quality |
| GO:0048870 | 0.00000 | 2.81465 | 24 | 58 | 1538 | cell motility |
| GO:0051674 | 0.00000 | 2.81465 | 24 | 58 | 1538 | localization of cell |
| GO:0048869 | 0.00000 | 2.13879 | 66 | 116 | 4334 | cellular developmental process |
| GO:0048856 | 0.00000 | 2.03796 | 88 | 141 | 5712 | anatomical structure development |
| GO:0009888 | 0.00000 | 2.61358 | 29 | 66 | 1899 | tissue development |
| GO:0071840 | 0.00000 | 2.00210 | 93 | 147 | 6096 | cellular component organization or biogenesis |
| GO:0065007 | 0.00000 | 1.98839 | 184 | 241 | 11983 | biological regulation |
| GO:0040011 | 0.00000 | 2.65812 | 27 | 62 | 1744 | locomotion |
| GO:0006928 | 0.00000 | 2.56333 | 30 | 66 | 1932 | movement of cell or subcellular component |
| GO:0007275 | 0.00000 | 2.03218 | 80 | 131 | 5227 | multicellular organism development |
| GO:0048519 | 0.00000 | 2.02818 | 79 | 130 | 5186 | negative regulation of biological process |
| GO:0009653 | 0.00000 | 2.32704 | 41 | 81 | 2652 | anatomical structure morphogenesis |
| GO:0009987 | 0.00000 | 2.17001 | 239 | 290 | 15608 | cellular process |
| GO:0016477 | 0.00000 | 2.80324 | 21 | 53 | 1397 | cell migration |
| GO:0051179 | 0.00000 | 1.97505 | 89 | 140 | 5794 | localization |
| GO:0050789 | 0.00000 | 1.92454 | 174 | 230 | 11369 | regulation of biological process |
| GO:0030154 | 0.00000 | 2.07319 | 63 | 109 | 4125 | cell differentiation |
| GO:0009966 | 0.00000 | 2.26725 | 42 | 81 | 2712 | regulation of signal transduction |
| GO:0048518 | 0.00000 | 1.93692 | 92 | 143 | 6033 | positive regulation of biological process |
| GO:0048523 | 0.00000 | 2.00648 | 71 | 117 | 4605 | negative regulation of cellular process |
| GO:0051049 | 0.00000 | 2.47511 | 29 | 63 | 1892 | regulation of transport |
| GO:0043062 | 0.00000 | 5.23051 | 4 | 21 | 292 | extracellular structure organization |
| GO:0048513 | 0.00000 | 2.10223 | 53 | 94 | 3430 | animal organ development |
| GO:0050793 | 0.00000 | 2.22295 | 41 | 79 | 2681 | regulation of developmental process |
| GO:0009887 | 0.00000 | 2.90877 | 16 | 42 | 1048 | animal organ morphogenesis |
| GO:0001503 | 0.00000 | 4.49887 | 6 | 23 | 369 | ossification |
| GO:0010646 | 0.00000 | 2.07515 | 50 | 89 | 3256 | regulation of cell communication |
| GO:0050673 | 0.00000 | 4.19109 | 6 | 24 | 412 | epithelial cell proliferation |
| GO:0051239 | 0.00000 | 2.07477 | 49 | 87 | 3173 | regulation of multicellular organismal process |
| GO:0023051 | 0.00000 | 2.05928 | 50 | 89 | 3277 | regulation of signaling |
| GO:0008283 | 0.00000 | 2.30379 | 30 | 62 | 1981 | cell proliferation |
| GO:0044281 | 0.00000 | 2.39898 | 26 | 56 | 1708 | small molecule metabolic process |
| GO:0006793 | 0.00000 | 2.08459 | 45 | 81 | 2914 | phosphorus metabolic process |
| GO:0007155 | 0.00000 | 2.61897 | 20 | 46 | 1273 | cell adhesion |
| GO:0022610 | 0.00000 | 2.59216 | 20 | 46 | 1285 | biological adhesion |
| GO:1902531 | 0.00000 | 2.37933 | 26 | 55 | 1687 | regulation of intracellular signal transduction |
| GO:0006796 | 0.00000 | 2.06804 | 44 | 80 | 2893 | phosphate-containing compound metabolic process |
| GO:0048522 | 0.00000 | 1.82920 | 82 | 125 | 5349 | positive regulation of cellular process |
| GO:0031589 | 0.00000 | 4.45069 | 5 | 20 | 322 | cell-substrate adhesion |
| GO:0065009 | 0.00000 | 2.12142 | 37 | 70 | 2437 | regulation of molecular function |
| GO:0023014 | 0.00000 | 2.96457 | 13 | 34 | 821 | signal transduction by protein phosphorylation |
| GO:0008219 | 0.00000 | 2.20921 | 31 | 62 | 2056 | cell death |
| GO:0042127 | 0.00000 | 2.35360 | 25 | 53 | 1636 | regulation of cell proliferation |
| GO:0051270 | 0.00000 | 2.74380 | 15 | 38 | 993 | regulation of cellular component movement |
| GO:0048583 | 0.00000 | 1.91172 | 58 | 95 | 3755 | regulation of response to stimulus |
| GO:0030198 | 0.00000 | 4.91749 | 4 | 17 | 248 | extracellular matrix organization |
| GO:0051050 | 0.00000 | 2.66436 | 16 | 39 | 1049 | positive regulation of transport |
| GO:0060548 | 0.00000 | 2.61555 | 16 | 39 | 1067 | negative regulation of cell death |
| GO:0040012 | 0.00000 | 2.68079 | 15 | 37 | 986 | regulation of locomotion |
| GO:0072359 | 0.00000 | 2.56791 | 17 | 40 | 1115 | circulatory system development |
| GO:0007166 | 0.00000 | 2.04805 | 38 | 69 | 2473 | cell surface receptor signaling pathway |
| GO:0050794 | 0.00000 | 1.69425 | 163 | 209 | 10650 | regulation of cellular process |
| GO:2000145 | 0.00000 | 2.74569 | 14 | 35 | 909 | regulation of cell motility |
| GO:2000026 | 0.00000 | 2.11586 | 33 | 62 | 2136 | regulation of multicellular organismal development |
| GO:0009967 | 0.00000 | 2.33799 | 23 | 48 | 1478 | positive regulation of signal transduction |
| GO:0051216 | 0.00000 | 5.22608 | 3 | 15 | 206 | cartilage development |
| GO:0030036 | 0.00000 | 3.10651 | 10 | 28 | 640 | actin cytoskeleton organization |
| GO:0042592 | 0.00000 | 2.18507 | 28 | 56 | 1857 | homeostatic process |
| GO:0030029 | 0.00000 | 2.95986 | 11 | 30 | 720 | actin filament-based process |
| GO:0048646 | 0.00000 | 2.51870 | 17 | 40 | 1135 | anatomical structure formation involved in morphogenesis |
| GO:0000165 | 0.00000 | 2.83256 | 12 | 32 | 803 | MAPK cascade |
| GO:0010648 | 0.00000 | 2.39999 | 20 | 44 | 1314 | negative regulation of cell communication |
| GO:0019222 | 0.00000 | 1.73282 | 89 | 130 | 5833 | regulation of metabolic process |
| GO:0023057 | 0.00000 | 2.39201 | 20 | 44 | 1318 | negative regulation of signaling |
| GO:0050790 | 0.00000 | 2.18905 | 27 | 54 | 1782 | regulation of catalytic activity |
| GO:0001501 | 0.00000 | 3.33140 | 8 | 24 | 510 | skeletal system development |
| GO:0030155 | 0.00000 | 2.98606 | 10 | 28 | 664 | regulation of cell adhesion |
| GO:0016310 | 0.00000 | 2.06482 | 33 | 61 | 2144 | phosphorylation |
| GO:0006810 | 0.00000 | 1.78842 | 66 | 102 | 4298 | transport |
| GO:0007165 | 0.00000 | 1.70480 | 92 | 132 | 6010 | signal transduction |
| GO:0010941 | 0.00000 | 2.18601 | 26 | 51 | 1677 | regulation of cell death |
| GO:0050678 | 0.00000 | 3.85313 | 5 | 19 | 349 | regulation of epithelial cell proliferation |
| GO:0051128 | 0.00000 | 1.97368 | 38 | 68 | 2513 | regulation of cellular component organization |
| GO:0035239 | 0.00000 | 2.61948 | 14 | 33 | 892 | tube morphogenesis |
| GO:0008152 | 0.00000 | 1.63082 | 158 | 201 | 10337 | metabolic process |
| GO:0006468 | 0.00000 | 2.11492 | 28 | 53 | 1801 | protein phosphorylation |
| GO:0010811 | 0.00000 | 6.42478 | 2 | 11 | 124 | positive regulation of cell-substrate adhesion |
| GO:0048514 | 0.00000 | 2.98737 | 9 | 26 | 614 | blood vessel morphogenesis |
| GO:0012501 | 0.00000 | 2.08601 | 29 | 55 | 1898 | programmed cell death |
| GO:0048585 | 0.00000 | 2.19497 | 24 | 48 | 1565 | negative regulation of response to stimulus |
| GO:0032535 | 0.00000 | 3.57270 | 6 | 20 | 395 | regulation of cellular component size |
| GO:0010810 | 0.00000 | 4.86342 | 3 | 14 | 205 | regulation of cell-substrate adhesion |
| GO:0051234 | 0.00000 | 1.74687 | 68 | 103 | 4428 | establishment of localization |
| GO:0019220 | 0.00000 | 2.15180 | 26 | 50 | 1665 | regulation of phosphate metabolic process |
| GO:0051174 | 0.00000 | 2.15037 | 26 | 50 | 1666 | regulation of phosphorus metabolic process |
| GO:0055085 | 0.00000 | 2.33338 | 19 | 41 | 1250 | transmembrane transport |
| GO:0006811 | 0.00000 | 2.20123 | 23 | 47 | 1526 | ion transport |
| GO:0001525 | 0.00000 | 3.20320 | 8 | 23 | 506 | angiogenesis |
| GO:0030334 | 0.00000 | 2.61764 | 13 | 32 | 864 | regulation of cell migration |
| GO:0010647 | 0.00000 | 2.09287 | 28 | 53 | 1818 | positive regulation of cell communication |
| GO:0023056 | 0.00000 | 2.08518 | 28 | 53 | 1824 | positive regulation of signaling |
| GO:0043408 | 0.00000 | 2.74169 | 11 | 29 | 746 | regulation of MAPK cascade |
| GO:0023052 | 0.00001 | 1.64579 | 100 | 139 | 6550 | signaling |
| GO:0090066 | 0.00001 | 3.04883 | 8 | 24 | 554 | regulation of anatomical structure size |
| GO:0043069 | 0.00001 | 2.50090 | 15 | 34 | 961 | negative regulation of programmed cell death |
| GO:0007154 | 0.00001 | 1.64280 | 101 | 140 | 6614 | cell communication |
| GO:0048584 | 0.00001 | 1.97375 | 34 | 61 | 2231 | positive regulation of response to stimulus |
| GO:0061448 | 0.00001 | 4.11065 | 4 | 16 | 275 | connective tissue development |
| GO:0009968 | 0.00001 | 2.33357 | 18 | 39 | 1185 | negative regulation of signal transduction |
| GO:0032970 | 0.00001 | 3.53732 | 6 | 19 | 378 | regulation of actin filament-based process |
| GO:0031323 | 0.00001 | 1.67596 | 81 | 117 | 5290 | regulation of cellular metabolic process |
| GO:0048878 | 0.00001 | 2.33512 | 18 | 38 | 1152 | chemical homeostasis |
| GO:0009893 | 0.00001 | 1.78959 | 52 | 83 | 3406 | positive regulation of metabolic process |
| GO:0006915 | 0.00001 | 2.04016 | 28 | 53 | 1860 | apoptotic process |
| GO:0043410 | 0.00001 | 3.02390 | 8 | 23 | 534 | positive regulation of MAPK cascade |
| GO:0071704 | 0.00001 | 1.58795 | 151 | 191 | 9839 | organic substance metabolic process |
| GO:0010817 | 0.00001 | 3.01786 | 8 | 23 | 535 | regulation of hormone levels |
| GO:0044092 | 0.00001 | 2.42183 | 15 | 34 | 990 | negative regulation of molecular function |
| GO:0050680 | 0.00001 | 5.62395 | 2 | 11 | 140 | negative regulation of epithelial cell proliferation |
| GO:0045785 | 0.00001 | 3.33872 | 6 | 19 | 399 | positive regulation of cell adhesion |
| GO:0001568 | 0.00002 | 2.66747 | 11 | 27 | 710 | blood vessel development |
| GO:0080090 | 0.00002 | 1.64882 | 79 | 113 | 5147 | regulation of primary metabolic process |
| GO:0032956 | 0.00002 | 3.59279 | 5 | 17 | 332 | regulation of actin cytoskeleton organization |
| GO:0001667 | 0.00002 | 3.30336 | 6 | 19 | 403 | ameboidal-type cell migration |
| GO:0035295 | 0.00002 | 2.29567 | 17 | 36 | 1105 | tube development |
| GO:0040007 | 0.00002 | 2.29342 | 17 | 36 | 1106 | growth |
| GO:0031214 | 0.00002 | 5.21706 | 2 | 11 | 150 | biomineral tissue development |
| GO:0044237 | 0.00002 | 1.55428 | 141 | 179 | 9199 | cellular metabolic process |
| GO:0016054 | 0.00002 | 4.34233 | 3 | 13 | 211 | organic acid catabolic process |
| GO:0046395 | 0.00002 | 4.34233 | 3 | 13 | 211 | carboxylic acid catabolic process |
| GO:0051897 | 0.00003 | 6.42523 | 2 | 9 | 101 | positive regulation of protein kinase B signaling |
| GO:0043066 | 0.00003 | 2.37664 | 14 | 32 | 945 | negative regulation of apoptotic process |
| GO:0007507 | 0.00003 | 2.74576 | 9 | 24 | 611 | heart development |
| GO:0032835 | 0.00003 | 8.97938 | 1 | 7 | 58 | glomerulus development |
| GO:0000902 | 0.00003 | 2.29145 | 16 | 34 | 1042 | cell morphogenesis |
| GO:1902533 | 0.00003 | 2.32052 | 15 | 33 | 998 | positive regulation of intracellular signal transduction |
| GO:0042325 | 0.00003 | 2.06327 | 23 | 44 | 1508 | regulation of phosphorylation |
| GO:0010604 | 0.00003 | 1.74976 | 48 | 76 | 3149 | positive regulation of macromolecule metabolic process |
| GO:0001944 | 0.00003 | 2.54442 | 11 | 27 | 742 | vasculature development |
| GO:0030325 | 0.00003 | 16.28419 | 0 | 5 | 25 | adrenal gland development |
| GO:0072012 | 0.00003 | 16.28419 | 0 | 5 | 25 | glomerulus vasculature development |
| GO:0019932 | 0.00003 | 3.12130 | 7 | 19 | 425 | second-messenger-mediated signaling |
| GO:0043269 | 0.00004 | 2.58429 | 11 | 26 | 703 | regulation of ion transport |
| GO:0034762 | 0.00004 | 2.83830 | 8 | 22 | 541 | regulation of transmembrane transport |
| GO:0032989 | 0.00004 | 2.21511 | 17 | 36 | 1142 | cellular component morphogenesis |
| GO:0022603 | 0.00004 | 2.26325 | 16 | 34 | 1054 | regulation of anatomical structure morphogenesis |
| GO:1901564 | 0.00004 | 1.57898 | 94 | 128 | 6130 | organonitrogen compound metabolic process |
| GO:0050896 | 0.00004 | 1.53381 | 144 | 181 | 9397 | response to stimulus |
| GO:0061437 | 0.00004 | 15.50807 | 0 | 5 | 26 | renal system vasculature development |
| GO:0061440 | 0.00004 | 15.50807 | 0 | 5 | 26 | kidney vasculature development |
| GO:0097435 | 0.00004 | 2.61238 | 10 | 25 | 668 | supramolecular fiber organization |
| GO:0006869 | 0.00004 | 3.46059 | 5 | 16 | 323 | lipid transport |
| GO:0030282 | 0.00004 | 5.96909 | 2 | 9 | 108 | bone mineralization |
| GO:0043067 | 0.00004 | 2.02918 | 23 | 44 | 1531 | regulation of programmed cell death |
| GO:0031325 | 0.00004 | 1.73361 | 48 | 75 | 3128 | positive regulation of cellular metabolic process |
| GO:0043086 | 0.00004 | 2.59989 | 10 | 25 | 671 | negative regulation of catalytic activity |
| GO:0072358 | 0.00004 | 2.49752 | 12 | 27 | 755 | cardiovascular system development |
| GO:0007015 | 0.00004 | 3.17061 | 6 | 18 | 396 | actin filament organization |
| GO:0008285 | 0.00005 | 2.58753 | 10 | 25 | 674 | negative regulation of cell proliferation |
| GO:0044238 | 0.00005 | 1.52699 | 142 | 179 | 9296 | primary metabolic process |
| GO:0060343 | 0.00005 | 14.80251 | 0 | 5 | 27 | trabecula formation |
| GO:0051241 | 0.00005 | 2.10071 | 20 | 39 | 1305 | negative regulation of multicellular organismal process |
| GO:0032501 | 0.00006 | 1.52927 | 124 | 159 | 8064 | multicellular organismal process |
| GO:0032368 | 0.00006 | 5.73627 | 2 | 9 | 112 | regulation of lipid transport |
| GO:0006812 | 0.00006 | 2.20437 | 17 | 34 | 1080 | cation transport |
| GO:0060347 | 0.00006 | 23.62810 | 0 | 4 | 15 | heart trabecula formation |
| GO:0034220 | 0.00007 | 2.35341 | 13 | 29 | 860 | ion transmembrane transport |
| GO:0048534 | 0.00007 | 2.27452 | 15 | 31 | 952 | hematopoietic or lymphoid organ development |
| GO:0002092 | 0.00007 | 13.56778 | 0 | 5 | 29 | positive regulation of receptor internalization |
| GO:0014066 | 0.00007 | 6.39221 | 1 | 8 | 90 | regulation of phosphatidylinositol 3-kinase signaling |
| GO:0002090 | 0.00007 | 7.62947 | 1 | 7 | 67 | regulation of receptor internalization |
| GO:0060255 | 0.00008 | 1.57361 | 83 | 114 | 5386 | regulation of macromolecule metabolic process |
| GO:1901615 | 0.00008 | 2.92316 | 7 | 19 | 452 | organic hydroxy compound metabolic process |
| GO:0007010 | 0.00008 | 2.08038 | 20 | 38 | 1281 | cytoskeleton organization |
| GO:0006629 | 0.00008 | 2.10134 | 19 | 37 | 1234 | lipid metabolic process |
| GO:0044282 | 0.00008 | 3.42699 | 5 | 15 | 305 | small molecule catabolic process |
| GO:0002062 | 0.00008 | 5.46950 | 2 | 9 | 117 | chondrocyte differentiation |
| GO:0034765 | 0.00008 | 2.91629 | 7 | 19 | 453 | regulation of ion transmembrane transport |
| GO:0043270 | 0.00009 | 3.40322 | 5 | 15 | 307 | positive regulation of ion transport |
| GO:0015850 | 0.00009 | 3.79965 | 4 | 13 | 239 | organic hydroxy compound transport |
| GO:0003007 | 0.00009 | 3.56188 | 4 | 14 | 274 | heart morphogenesis |
| GO:0014065 | 0.00010 | 5.32098 | 2 | 9 | 120 | phosphatidylinositol 3-kinase signaling |
| GO:0060537 | 0.00010 | 2.86911 | 7 | 19 | 460 | muscle tissue development |
| GO:0001932 | 0.00011 | 2.00954 | 21 | 40 | 1396 | regulation of protein phosphorylation |
| GO:2000147 | 0.00011 | 2.67483 | 8 | 21 | 545 | positive regulation of cell motility |
| GO:0043549 | 0.00012 | 2.43657 | 11 | 25 | 713 | regulation of kinase activity |
| GO:0051246 | 0.00014 | 1.72630 | 40 | 64 | 2642 | regulation of protein metabolic process |
| GO:0055114 | 0.00014 | 2.21696 | 14 | 30 | 942 | oxidation-reduction process |
| GO:0034308 | 0.00014 | 8.51068 | 1 | 6 | 52 | primary alcohol metabolic process |
| GO:0042572 | 0.00014 | 18.56250 | 0 | 4 | 18 | retinol metabolic process |
| GO:0034764 | 0.00014 | 3.85899 | 3 | 12 | 217 | positive regulation of transmembrane transport |
| GO:0042981 | 0.00014 | 1.94841 | 23 | 42 | 1512 | regulation of apoptotic process |
| GO:0001934 | 0.00014 | 2.18299 | 15 | 31 | 989 | positive regulation of protein phosphorylation |
| GO:0048468 | 0.00015 | 1.76564 | 36 | 58 | 2330 | cell development |
| GO:0051051 | 0.00015 | 2.69773 | 8 | 20 | 514 | negative regulation of transport |
| GO:0030097 | 0.00015 | 2.23858 | 14 | 29 | 901 | hemopoiesis |
| GO:0006066 | 0.00015 | 3.39031 | 4 | 14 | 287 | alcohol metabolic process |
| GO:0030500 | 0.00015 | 6.72952 | 1 | 7 | 75 | regulation of bone mineralization |
| GO:0051171 | 0.00015 | 1.55527 | 77 | 106 | 5008 | regulation of nitrogen compound metabolic process |
| GO:1904062 | 0.00016 | 3.21356 | 5 | 15 | 324 | regulation of cation transmembrane transport |
| GO:0010876 | 0.00016 | 3.07424 | 6 | 16 | 361 | lipid localization |
| GO:0045595 | 0.00016 | 1.84167 | 29 | 49 | 1874 | regulation of cell differentiation |
| GO:0051493 | 0.00017 | 2.67010 | 8 | 20 | 519 | regulation of cytoskeleton organization |
| GO:0051272 | 0.00017 | 2.59371 | 9 | 21 | 561 | positive regulation of cellular component movement |
| GO:0051338 | 0.00018 | 2.28607 | 13 | 27 | 820 | regulation of transferase activity |
| GO:0043405 | 0.00019 | 3.31652 | 4 | 14 | 293 | regulation of MAP kinase activity |
| GO:0045859 | 0.00019 | 2.45570 | 10 | 23 | 649 | regulation of protein kinase activity |
| GO:0072239 | 0.00019 | 38.88612 | 0 | 3 | 8 | metanephric glomerulus vasculature development |
| GO:0002520 | 0.00019 | 2.14097 | 15 | 31 | 1007 | immune system development |
| GO:0001649 | 0.00019 | 3.99907 | 3 | 11 | 192 | osteoblast differentiation |
| GO:0030335 | 0.00020 | 2.63234 | 8 | 20 | 526 | positive regulation of cell migration |
| GO:0030278 | 0.00020 | 3.69523 | 3 | 12 | 226 | regulation of ossification |
| GO:0048260 | 0.00021 | 7.82846 | 1 | 6 | 56 | positive regulation of receptor-mediated endocytosis |
| GO:0048259 | 0.00022 | 5.40017 | 2 | 8 | 105 | regulation of receptor-mediated endocytosis |
| GO:0048389 | 0.00023 | Inf | 0 | 2 | 2 | intermediate mesoderm development |
| GO:0061227 | 0.00023 | Inf | 0 | 2 | 2 | pattern specification involved in mesonephros development |
| GO:0072098 | 0.00023 | Inf | 0 | 2 | 2 | anterior/posterior pattern specification involved in kidney development |
| GO:0019934 | 0.00024 | 10.17228 | 1 | 5 | 37 | cGMP-mediated signaling |
| GO:0040017 | 0.00025 | 2.51727 | 9 | 21 | 577 | positive regulation of locomotion |
| GO:0034767 | 0.00025 | 4.21058 | 3 | 10 | 166 | positive regulation of ion transmembrane transport |
| GO:0042063 | 0.00026 | 3.21160 | 5 | 14 | 302 | gliogenesis |
| GO:0043933 | 0.00026 | 1.80296 | 29 | 49 | 1910 | protein-containing complex subunit organization |
| GO:0071900 | 0.00027 | 2.81151 | 6 | 17 | 418 | regulation of protein serine/threonine kinase activity |
| GO:0050801 | 0.00028 | 2.25356 | 12 | 26 | 799 | ion homeostasis |
| GO:0014074 | 0.00028 | 5.18539 | 2 | 8 | 109 | response to purine-containing compound |
| GO:0048729 | 0.00028 | 2.38133 | 10 | 23 | 668 | tissue morphogenesis |
| GO:0071702 | 0.00029 | 1.70733 | 37 | 59 | 2444 | organic substance transport |
| GO:0051247 | 0.00029 | 1.86114 | 25 | 43 | 1616 | positive regulation of protein metabolic process |
| GO:0051094 | 0.00030 | 1.88911 | 23 | 41 | 1516 | positive regulation of developmental process |
| GO:0014910 | 0.00031 | 5.94061 | 1 | 7 | 84 | regulation of smooth muscle cell migration |
| GO:0098655 | 0.00031 | 2.36623 | 10 | 23 | 672 | cation transmembrane transport |
| GO:0032412 | 0.00032 | 3.51287 | 4 | 12 | 237 | regulation of ion transmembrane transporter activity |
| GO:0022607 | 0.00032 | 1.66704 | 42 | 64 | 2723 | cellular component assembly |
| GO:0032268 | 0.00032 | 1.69938 | 38 | 59 | 2454 | regulation of cellular protein metabolic process |
| GO:0051271 | 0.00032 | 3.13442 | 5 | 14 | 309 | negative regulation of cellular component movement |
| GO:0042327 | 0.00032 | 2.07428 | 16 | 31 | 1037 | positive regulation of phosphorylation |
| GO:0051173 | 0.00033 | 1.63658 | 46 | 69 | 3000 | positive regulation of nitrogen compound metabolic process |
| GO:0072006 | 0.00033 | 4.47033 | 2 | 9 | 141 | nephron development |
| GO:0051716 | 0.00034 | 1.46010 | 118 | 149 | 7705 | cellular response to stimulus |
| GO:0070371 | 0.00034 | 2.97879 | 5 | 15 | 348 | ERK1 and ERK2 cascade |
| GO:0048732 | 0.00034 | 2.66688 | 7 | 18 | 466 | gland development |
| GO:1905952 | 0.00035 | 4.43652 | 2 | 9 | 142 | regulation of lipid localization |
| GO:0008361 | 0.00036 | 3.70967 | 3 | 11 | 206 | regulation of cell size |
| GO:0051093 | 0.00037 | 2.05717 | 16 | 31 | 1045 | negative regulation of developmental process |
| GO:0031399 | 0.00038 | 1.81219 | 27 | 45 | 1737 | regulation of protein modification process |
| GO:0061061 | 0.00038 | 2.32927 | 10 | 23 | 682 | muscle structure development |
| GO:1902532 | 0.00038 | 2.56054 | 8 | 19 | 512 | negative regulation of intracellular signal transduction |
| GO:0019935 | 0.00039 | 3.67168 | 3 | 11 | 208 | cyclic-nucleotide-mediated signaling |
| GO:0048015 | 0.00039 | 4.37041 | 2 | 9 | 144 | phosphatidylinositol-mediated signaling |
| GO:0016049 | 0.00039 | 2.55524 | 8 | 19 | 513 | cell growth |
| GO:0035265 | 0.00040 | 3.65298 | 3 | 11 | 209 | organ growth |
| GO:0022898 | 0.00043 | 3.39106 | 4 | 12 | 245 | regulation of transmembrane transporter activity |
| GO:0051130 | 0.00043 | 1.94788 | 19 | 35 | 1248 | positive regulation of cellular component organization |
| GO:0031401 | 0.00045 | 1.96309 | 18 | 34 | 1202 | positive regulation of protein modification process |
| GO:0048017 | 0.00045 | 4.27484 | 2 | 9 | 147 | inositol lipid-mediated signaling |
| GO:0010562 | 0.00045 | 2.00556 | 17 | 32 | 1106 | positive regulation of phosphorus metabolic process |
| GO:0045937 | 0.00045 | 2.00556 | 17 | 32 | 1106 | positive regulation of phosphate metabolic process |
| GO:0001764 | 0.00046 | 3.88446 | 3 | 10 | 179 | neuron migration |
| GO:0070167 | 0.00047 | 5.50972 | 1 | 7 | 90 | regulation of biomineral tissue development |
| GO:0006898 | 0.00047 | 3.58001 | 3 | 11 | 213 | receptor-mediated endocytosis |
| GO:0003206 | 0.00048 | 4.24390 | 2 | 9 | 148 | cardiac chamber morphogenesis |
| GO:0035051 | 0.00048 | 3.86144 | 3 | 10 | 180 | cardiocyte differentiation |
| GO:0014909 | 0.00050 | 5.44389 | 1 | 7 | 91 | smooth muscle cell migration |
| GO:0043436 | 0.00051 | 2.09480 | 14 | 28 | 924 | oxoacid metabolic process |
| GO:0009914 | 0.00051 | 2.85683 | 6 | 15 | 362 | hormone transport |
| GO:0001775 | 0.00052 | 2.01146 | 16 | 31 | 1067 | cell activation |
| GO:0022008 | 0.00052 | 1.79368 | 26 | 44 | 1712 | neurogenesis |
| GO:0044085 | 0.00053 | 1.61469 | 45 | 67 | 2940 | cellular component biogenesis |
| GO:0072102 | 0.00054 | 24.30064 | 0 | 3 | 11 | glomerulus morphogenesis |
| GO:0072178 | 0.00054 | 24.30064 | 0 | 3 | 11 | nephric duct morphogenesis |
| GO:0040013 | 0.00055 | 2.96141 | 5 | 14 | 326 | negative regulation of locomotion |
| GO:0032270 | 0.00055 | 1.83987 | 23 | 40 | 1513 | positive regulation of cellular protein metabolic process |
| GO:0032386 | 0.00056 | 2.63099 | 7 | 17 | 445 | regulation of intracellular transport |
| GO:0031623 | 0.00056 | 4.63229 | 2 | 8 | 121 | receptor internalization |
| GO:0032370 | 0.00056 | 6.41368 | 1 | 6 | 67 | positive regulation of lipid transport |
| GO:0048738 | 0.00057 | 3.27733 | 4 | 12 | 253 | cardiac muscle tissue development |
| GO:0051896 | 0.00058 | 4.12446 | 2 | 9 | 152 | regulation of protein kinase B signaling |
| GO:0110053 | 0.00059 | 3.26365 | 4 | 12 | 254 | regulation of actin filament organization |
| GO:0010959 | 0.00059 | 2.70703 | 6 | 16 | 407 | regulation of metal ion transport |
| GO:0043406 | 0.00060 | 3.47582 | 3 | 11 | 219 | positive regulation of MAP kinase activity |
| GO:0032409 | 0.00061 | 3.25007 | 4 | 12 | 255 | regulation of transporter activity |
| GO:0060341 | 0.00061 | 2.06836 | 14 | 28 | 935 | regulation of cellular localization |
| GO:0070372 | 0.00062 | 2.92340 | 5 | 14 | 330 | regulation of ERK1 and ERK2 cascade |
| GO:0016042 | 0.00063 | 3.05955 | 4 | 13 | 293 | lipid catabolic process |
| GO:0034754 | 0.00065 | 5.19553 | 1 | 7 | 95 | cellular hormone metabolic process |
| GO:0046683 | 0.00065 | 5.19553 | 1 | 7 | 95 | response to organophosphorus |
| GO:0051240 | 0.00066 | 1.73952 | 29 | 47 | 1887 | positive regulation of multicellular organismal process |
| GO:0035993 | 0.00069 | 129.27684 | 0 | 2 | 3 | deltoid tuberosity development |
| GO:0044691 | 0.00069 | 129.27684 | 0 | 2 | 3 | tooth eruption |
| GO:0072190 | 0.00069 | 129.27684 | 0 | 2 | 3 | ureter urothelium development |
| GO:0097195 | 0.00069 | 129.27684 | 0 | 2 | 3 | pilomotor reflex |
| GO:2000857 | 0.00069 | 129.27684 | 0 | 2 | 3 | positive regulation of mineralocorticoid secretion |
| GO:2000860 | 0.00069 | 129.27684 | 0 | 2 | 3 | positive regulation of aldosterone secretion |
| GO:0072176 | 0.00071 | 21.59962 | 0 | 3 | 12 | nephric duct development |
| GO:2001234 | 0.00072 | 3.39348 | 3 | 11 | 224 | negative regulation of apoptotic signaling pathway |
| GO:0048745 | 0.00072 | 11.29447 | 0 | 4 | 27 | smooth muscle tissue development |
| GO:0072001 | 0.00072 | 3.01592 | 5 | 13 | 297 | renal system development |
| GO:0048705 | 0.00072 | 3.18384 | 4 | 12 | 260 | skeletal system morphogenesis |
| GO:0009605 | 0.00074 | 1.64845 | 37 | 57 | 2429 | response to external stimulus |
| GO:0006807 | 0.00074 | 1.41676 | 134 | 164 | 8771 | nitrogen compound metabolic process |
| GO:0006082 | 0.00075 | 2.03792 | 15 | 28 | 948 | organic acid metabolic process |
| GO:0009719 | 0.00077 | 1.84859 | 21 | 37 | 1388 | response to endogenous stimulus |
| GO:0048589 | 0.00079 | 2.16009 | 12 | 24 | 765 | developmental growth |
| GO:0001655 | 0.00083 | 2.83247 | 5 | 14 | 340 | urogenital system development |
| GO:0030511 | 0.00083 | 10.82339 | 0 | 4 | 28 | positive regulation of transforming growth factor beta receptor signaling pathway |
| GO:1903846 | 0.00083 | 10.82339 | 0 | 4 | 28 | positive regulation of cellular response to transforming growth factor beta stimulus |
| GO:0046887 | 0.00083 | 3.90457 | 2 | 9 | 160 | positive regulation of hormone secretion |
| GO:0050679 | 0.00089 | 3.54601 | 3 | 10 | 195 | positive regulation of epithelial cell proliferation |
| GO:0007167 | 0.00090 | 2.07008 | 13 | 26 | 865 | enzyme linked receptor protein signaling pathway |
| GO:0060272 | 0.00091 | 19.43881 | 0 | 3 | 13 | embryonic skeletal joint morphogenesis |
| GO:2001236 | 0.00091 | 3.85320 | 2 | 9 | 162 | regulation of extrinsic apoptotic signaling pathway |
| GO:0034110 | 0.00095 | 10.39000 | 0 | 4 | 29 | regulation of homotypic cell-cell adhesion |
| GO:0030001 | 0.00096 | 2.09301 | 13 | 25 | 822 | metal ion transport |
| GO:0060350 | 0.00096 | 5.75168 | 1 | 6 | 74 | endochondral bone morphogenesis |
| GO:0007264 | 0.00097 | 2.49425 | 7 | 17 | 468 | small GTPase mediated signal transduction |
| GO:0097190 | 0.00098 | 2.30111 | 9 | 20 | 597 | apoptotic signaling pathway |
| GO:0060429 | 0.00101 | 1.90482 | 18 | 32 | 1160 | epithelium development |
| GO:0055006 | 0.00105 | 4.76089 | 2 | 7 | 103 | cardiac cell development |
| GO:0098662 | 0.00106 | 2.28485 | 9 | 20 | 601 | inorganic cation transmembrane transport |
| GO:0045860 | 0.00106 | 2.55402 | 7 | 16 | 430 | positive regulation of protein kinase activity |
| GO:0098771 | 0.00106 | 2.14763 | 11 | 23 | 736 | inorganic ion homeostasis |
| GO:0007254 | 0.00108 | 3.45193 | 3 | 10 | 200 | JNK cascade |
| GO:0061572 | 0.00108 | 3.75436 | 3 | 9 | 166 | actin filament bundle organization |
| GO:0032890 | 0.00110 | 5.58686 | 1 | 6 | 76 | regulation of organic acid transport |
| GO:0040008 | 0.00112 | 2.13834 | 11 | 23 | 739 | regulation of growth |
| GO:0008154 | 0.00112 | 3.43371 | 3 | 10 | 201 | actin polymerization or depolymerization |
| GO:0071902 | 0.00113 | 3.01185 | 4 | 12 | 274 | positive regulation of protein serine/threonine kinase activity |
| GO:0007399 | 0.00114 | 1.64116 | 35 | 53 | 2257 | nervous system development |
| GO:0006577 | 0.00114 | 17.67087 | 0 | 3 | 14 | amino-acid betaine metabolic process |
| GO:0072224 | 0.00114 | 17.67087 | 0 | 3 | 14 | metanephric glomerulus development |
| GO:0001822 | 0.00117 | 3.00027 | 4 | 12 | 275 | kidney development |
| GO:2000146 | 0.00117 | 3.00027 | 4 | 12 | 275 | negative regulation of cell motility |
| GO:0051346 | 0.00117 | 2.61893 | 6 | 15 | 393 | negative regulation of hydrolase activity |
| GO:0014812 | 0.00118 | 4.66332 | 2 | 7 | 105 | muscle cell migration |
| GO:2000379 | 0.00118 | 4.66332 | 2 | 7 | 105 | positive regulation of reactive oxygen species metabolic process |
| GO:0046879 | 0.00118 | 2.72228 | 5 | 14 | 353 | hormone secretion |
| GO:0019752 | 0.00121 | 2.02495 | 14 | 26 | 883 | carboxylic acid metabolic process |
| GO:0030100 | 0.00125 | 2.97736 | 4 | 12 | 277 | regulation of endocytosis |
| GO:0042445 | 0.00125 | 3.38016 | 3 | 10 | 204 | hormone metabolic process |
| GO:0010631 | 0.00128 | 2.96603 | 4 | 12 | 278 | epithelial cell migration |
| GO:0061383 | 0.00129 | 6.77677 | 1 | 5 | 53 | trabecula morphogenesis |
| GO:0014706 | 0.00131 | 2.49868 | 7 | 16 | 439 | striated muscle tissue development |
| GO:0065003 | 0.00135 | 1.72351 | 26 | 42 | 1690 | protein-containing complex assembly |
| GO:0006979 | 0.00136 | 2.57732 | 6 | 15 | 399 | response to oxidative stress |
| GO:0090132 | 0.00136 | 2.94364 | 4 | 12 | 280 | epithelium migration |
| GO:0006578 | 0.00138 | 64.63559 | 0 | 2 | 4 | amino-acid betaine biosynthetic process |
| GO:0035990 | 0.00138 | 64.63559 | 0 | 2 | 4 | tendon cell differentiation |
| GO:0035992 | 0.00138 | 64.63559 | 0 | 2 | 4 | tendon formation |
| GO:0038146 | 0.00138 | 64.63559 | 0 | 2 | 4 | chemokine (C-X-C motif) ligand 12 signaling pathway |
| GO:2000298 | 0.00138 | 64.63559 | 0 | 2 | 4 | regulation of Rho-dependent protein serine/threonine kinase activity |
| GO:2000669 | 0.00138 | 64.63559 | 0 | 2 | 4 | negative regulation of dendritic cell apoptotic process |
| GO:0043085 | 0.00139 | 1.92659 | 16 | 29 | 1036 | positive regulation of catalytic activity |
| GO:0006935 | 0.00140 | 2.28083 | 9 | 19 | 571 | chemotaxis |
| GO:0060192 | 0.00141 | 16.19759 | 0 | 3 | 15 | negative regulation of lipase activity |
| GO:0072498 | 0.00141 | 16.19759 | 0 | 3 | 15 | embryonic skeletal joint development |
| GO:0090130 | 0.00145 | 2.92158 | 4 | 12 | 282 | tissue migration |
| GO:0034101 | 0.00145 | 3.96221 | 2 | 8 | 140 | erythrocyte homeostasis |
| GO:0042330 | 0.00146 | 2.27239 | 9 | 19 | 573 | taxis |
| GO:0090100 | 0.00146 | 4.47966 | 2 | 7 | 109 | positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
| GO:0002262 | 0.00150 | 3.57108 | 3 | 9 | 174 | myeloid cell homeostasis |
| GO:0055007 | 0.00152 | 3.93224 | 2 | 8 | 141 | cardiac muscle cell differentiation |
| GO:0048568 | 0.00152 | 2.38621 | 7 | 17 | 488 | embryonic organ development |
| GO:0010033 | 0.00153 | 1.54440 | 46 | 66 | 3005 | response to organic substance |
| GO:0021591 | 0.00156 | 8.95533 | 1 | 4 | 33 | ventricular system development |
| GO:1901099 | 0.00156 | 8.95533 | 1 | 4 | 33 | negative regulation of signal transduction in absence of ligand |
| GO:2001240 | 0.00156 | 8.95533 | 1 | 4 | 33 | negative regulation of extrinsic apoptotic signaling pathway in absence of ligand |
| GO:0044057 | 0.00158 | 2.25570 | 9 | 19 | 577 | regulation of system process |
| GO:0019216 | 0.00158 | 2.75080 | 5 | 13 | 324 | regulation of lipid metabolic process |
| GO:1901135 | 0.00160 | 1.95474 | 15 | 27 | 949 | carbohydrate derivative metabolic process |
| GO:0008064 | 0.00163 | 3.52800 | 3 | 9 | 176 | regulation of actin polymerization or depolymerization |
| GO:0070374 | 0.00168 | 3.03367 | 4 | 11 | 249 | positive regulation of ERK1 and ERK2 cascade |
| GO:0042476 | 0.00171 | 4.35110 | 2 | 7 | 112 | odontogenesis |
| GO:0010566 | 0.00172 | 14.95097 | 0 | 3 | 16 | regulation of ketone biosynthetic process |
| GO:1901379 | 0.00174 | 5.07740 | 1 | 6 | 83 | regulation of potassium ion transmembrane transport |
| GO:1901016 | 0.00179 | 6.25438 | 1 | 5 | 57 | regulation of potassium ion transmembrane transporter activity |
| GO:0010675 | 0.00181 | 3.81676 | 2 | 8 | 145 | regulation of cellular carbohydrate metabolic process |
| GO:0030832 | 0.00183 | 3.46528 | 3 | 9 | 179 | regulation of actin filament length |
| GO:0055080 | 0.00183 | 2.09045 | 11 | 22 | 721 | cation homeostasis |
| GO:0015672 | 0.00185 | 2.41150 | 7 | 16 | 454 | monovalent inorganic cation transport |
| GO:0009058 | 0.00189 | 1.43359 | 77 | 100 | 5000 | biosynthetic process |
| GO:0051347 | 0.00190 | 2.27236 | 8 | 18 | 542 | positive regulation of transferase activity |
| GO:0000186 | 0.00195 | 8.37683 | 1 | 4 | 35 | activation of MAPKK activity |
| GO:1903959 | 0.00195 | 8.37683 | 1 | 4 | 35 | regulation of anion transmembrane transport |
| GO:1901342 | 0.00196 | 2.68086 | 5 | 13 | 332 | regulation of vasculature development |
| GO:0043491 | 0.00197 | 3.42469 | 3 | 9 | 181 | protein kinase B signaling |
| GO:0060627 | 0.00197 | 2.26352 | 8 | 18 | 544 | regulation of vesicle-mediated transport |
| GO:0044255 | 0.00198 | 1.94922 | 14 | 26 | 915 | cellular lipid metabolic process |
| GO:0062012 | 0.00201 | 2.67237 | 5 | 13 | 333 | regulation of small molecule metabolic process |
| GO:0071363 | 0.00203 | 2.20306 | 9 | 19 | 590 | cellular response to growth factor stimulus |
| GO:0007229 | 0.00208 | 4.88636 | 1 | 6 | 86 | integrin-mediated signaling pathway |
| GO:0009891 | 0.00209 | 1.65088 | 29 | 45 | 1889 | positive regulation of biosynthetic process |
| GO:0001755 | 0.00209 | 6.02221 | 1 | 5 | 59 | neural crest cell migration |
| GO:0044070 | 0.00209 | 4.19069 | 2 | 7 | 116 | regulation of anion transport |
| GO:0060349 | 0.00209 | 4.19069 | 2 | 7 | 116 | bone morphogenesis |
| GO:0003417 | 0.00217 | 8.11470 | 1 | 4 | 36 | growth plate cartilage development |
| GO:0061384 | 0.00217 | 8.11470 | 1 | 4 | 36 | heart trabecula morphogenesis |
| GO:1903792 | 0.00217 | 8.11470 | 1 | 4 | 36 | negative regulation of anion transport |
| GO:1905954 | 0.00221 | 4.82582 | 1 | 6 | 87 | positive regulation of lipid localization |
| GO:0009725 | 0.00222 | 2.09439 | 11 | 21 | 686 | response to hormone |
| GO:1904064 | 0.00224 | 3.68156 | 2 | 8 | 150 | positive regulation of cation transmembrane transport |
| GO:0014911 | 0.00225 | 5.91246 | 1 | 5 | 60 | positive regulation of smooth muscle cell migration |
| GO:0033157 | 0.00227 | 3.10550 | 3 | 10 | 221 | regulation of intracellular protein transport |
| GO:0002317 | 0.00227 | 43.08851 | 0 | 2 | 5 | plasma cell differentiation |
| GO:0002740 | 0.00227 | 43.08851 | 0 | 2 | 5 | negative regulation of cytokine secretion involved in immune response |
| GO:0008284 | 0.00230 | 1.90097 | 15 | 27 | 974 | positive regulation of cell proliferation |
| GO:1905114 | 0.00232 | 2.28697 | 8 | 17 | 508 | cell surface receptor signaling pathway involved in cell-cell signaling |
| GO:0051046 | 0.00234 | 1.95064 | 13 | 25 | 878 | regulation of secretion |
| GO:0045834 | 0.00234 | 3.65565 | 2 | 8 | 151 | positive regulation of lipid metabolic process |
| GO:0003012 | 0.00234 | 2.51844 | 6 | 14 | 380 | muscle system process |
| GO:0072507 | 0.00237 | 2.28222 | 8 | 17 | 509 | divalent inorganic cation homeostasis |
| GO:0046328 | 0.00237 | 3.32721 | 3 | 9 | 186 | regulation of JNK cascade |
| GO:0002521 | 0.00240 | 2.22029 | 8 | 18 | 554 | leukocyte differentiation |
| GO:0071320 | 0.00240 | 7.86846 | 1 | 4 | 37 | cellular response to cAMP |
| GO:0033627 | 0.00242 | 5.80662 | 1 | 5 | 61 | cell adhesion mediated by integrin |
| GO:0030336 | 0.00243 | 2.88653 | 4 | 11 | 261 | negative regulation of cell migration |
| GO:0033674 | 0.00245 | 2.34063 | 7 | 16 | 467 | positive regulation of kinase activity |
| GO:0098660 | 0.00251 | 2.11286 | 10 | 20 | 647 | inorganic ion transmembrane transport |
| GO:0023061 | 0.00256 | 2.26341 | 8 | 17 | 513 | signal release |
| GO:1902903 | 0.00260 | 2.59024 | 5 | 13 | 343 | regulation of supramolecular fiber organization |
| GO:0070848 | 0.00263 | 2.14899 | 9 | 19 | 604 | response to growth factor |
| GO:0044242 | 0.00264 | 3.27133 | 3 | 9 | 189 | cellular lipid catabolic process |
| GO:0072210 | 0.00265 | 7.63670 | 1 | 4 | 38 | metanephric nephron development |
| GO:0050803 | 0.00265 | 2.85192 | 4 | 11 | 264 | regulation of synapse structure or activity |
| GO:0046903 | 0.00268 | 1.79766 | 18 | 31 | 1184 | secretion |
| GO:1901137 | 0.00269 | 2.19512 | 9 | 18 | 560 | carbohydrate derivative biosynthetic process |
| GO:0042060 | 0.00273 | 2.57441 | 5 | 13 | 345 | wound healing |
| GO:0007266 | 0.00283 | 3.23509 | 3 | 9 | 191 | Rho protein signal transduction |
| GO:0097191 | 0.00284 | 3.00485 | 3 | 10 | 228 | extrinsic apoptotic signaling pathway |
| GO:0030833 | 0.00286 | 3.53138 | 2 | 8 | 156 | regulation of actin filament polymerization |
| GO:0002043 | 0.00288 | 12.14607 | 0 | 3 | 19 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis |
| GO:0032930 | 0.00288 | 12.14607 | 0 | 3 | 19 | positive regulation of superoxide anion generation |
| GO:0001558 | 0.00292 | 2.36988 | 7 | 15 | 432 | regulation of cell growth |
| GO:0001570 | 0.00293 | 4.54425 | 1 | 6 | 92 | vasculogenesis |
| GO:0055065 | 0.00293 | 2.08212 | 10 | 20 | 656 | metal ion homeostasis |
| GO:0010628 | 0.00298 | 1.61650 | 29 | 45 | 1925 | positive regulation of gene expression |
| GO:0055074 | 0.00301 | 2.28884 | 7 | 16 | 477 | calcium ion homeostasis |
| GO:0060485 | 0.00306 | 2.79603 | 4 | 11 | 269 | mesenchyme development |
| GO:0044283 | 0.00309 | 2.11557 | 9 | 19 | 613 | small molecule biosynthetic process |
| GO:0033002 | 0.00312 | 2.96367 | 4 | 10 | 231 | muscle cell proliferation |
| GO:0044089 | 0.00312 | 2.21769 | 8 | 17 | 523 | positive regulation of cellular component biogenesis |
| GO:0003205 | 0.00314 | 3.18221 | 3 | 9 | 194 | cardiac chamber development |
| GO:0051591 | 0.00319 | 5.41857 | 1 | 5 | 65 | response to cAMP |
| GO:0060389 | 0.00319 | 5.41857 | 1 | 5 | 65 | pathway-restricted SMAD protein phosphorylation |
| GO:0071364 | 0.00320 | 7.21181 | 1 | 4 | 40 | cellular response to epidermal growth factor stimulus |
| GO:1901576 | 0.00334 | 1.40609 | 75 | 97 | 4910 | organic substance biosynthetic process |
| GO:0006575 | 0.00334 | 3.43784 | 2 | 8 | 160 | cellular modified amino acid metabolic process |
| GO:0002313 | 0.00335 | 11.43109 | 0 | 3 | 20 | mature B cell differentiation involved in immune response |
| GO:0034368 | 0.00335 | 11.43109 | 0 | 3 | 20 | protein-lipid complex remodeling |
| GO:0034369 | 0.00335 | 11.43109 | 0 | 3 | 20 | plasma lipoprotein particle remodeling |
| GO:0010746 | 0.00337 | 32.31497 | 0 | 2 | 6 | regulation of plasma membrane long-chain fatty acid transport |
| GO:0010754 | 0.00337 | 32.31497 | 0 | 2 | 6 | negative regulation of cGMP-mediated signaling |
| GO:0016576 | 0.00337 | 32.31497 | 0 | 2 | 6 | histone dephosphorylation |
| GO:0034112 | 0.00337 | 32.31497 | 0 | 2 | 6 | positive regulation of homotypic cell-cell adhesion |
| GO:0072103 | 0.00337 | 32.31497 | 0 | 2 | 6 | glomerulus vasculature morphogenesis |
| GO:0072104 | 0.00337 | 32.31497 | 0 | 2 | 6 | glomerular capillary formation |
| GO:1905049 | 0.00337 | 32.31497 | 0 | 2 | 6 | negative regulation of metallopeptidase activity |
| GO:0044093 | 0.00338 | 1.70818 | 22 | 35 | 1408 | positive regulation of molecular function |
| GO:0061035 | 0.00341 | 5.32950 | 1 | 5 | 66 | regulation of cartilage development |
| GO:0048872 | 0.00341 | 2.61709 | 5 | 12 | 313 | homeostasis of number of cells |
| GO:0070201 | 0.00353 | 2.00724 | 11 | 21 | 714 | regulation of establishment of protein localization |
| GO:0006950 | 0.00357 | 1.45844 | 54 | 73 | 3512 | response to stress |
| GO:1904018 | 0.00359 | 3.11431 | 3 | 9 | 198 | positive regulation of vasculature development |
| GO:0007265 | 0.00370 | 2.38583 | 6 | 14 | 400 | Ras protein signal transduction |
| GO:0007162 | 0.00372 | 2.72133 | 4 | 11 | 276 | negative regulation of cell adhesion |
| GO:0045807 | 0.00374 | 3.37086 | 2 | 8 | 163 | positive regulation of endocytosis |
| GO:0032963 | 0.00381 | 4.29363 | 1 | 6 | 97 | collagen metabolic process |
| GO:0055013 | 0.00381 | 4.29363 | 1 | 6 | 97 | cardiac muscle cell development |
| GO:2001237 | 0.00381 | 4.29363 | 1 | 6 | 97 | negative regulation of extrinsic apoptotic signaling pathway |
| GO:0051260 | 0.00382 | 2.46871 | 5 | 13 | 359 | protein homooligomerization |
| GO:0032331 | 0.00386 | 10.79556 | 0 | 3 | 21 | negative regulation of chondrocyte differentiation |
| GO:0072111 | 0.00386 | 10.79556 | 0 | 3 | 21 | cell proliferation involved in kidney development |
| GO:0006081 | 0.00388 | 5.15986 | 1 | 5 | 68 | cellular aldehyde metabolic process |
| GO:0000904 | 0.00391 | 1.95459 | 12 | 22 | 768 | cell morphogenesis involved in differentiation |
| GO:0051928 | 0.00395 | 3.71142 | 2 | 7 | 130 | positive regulation of calcium ion transport |
| GO:0021782 | 0.00400 | 4.24677 | 2 | 6 | 98 | glial cell development |
| GO:0060993 | 0.00400 | 4.24677 | 2 | 6 | 98 | kidney morphogenesis |
| GO:0043271 | 0.00402 | 3.32762 | 3 | 8 | 165 | negative regulation of ion transport |
| GO:2001233 | 0.00404 | 2.36094 | 6 | 14 | 404 | regulation of apoptotic signaling pathway |
| GO:0044249 | 0.00410 | 1.39729 | 74 | 95 | 4824 | cellular biosynthetic process |
| GO:0051336 | 0.00413 | 1.83716 | 15 | 26 | 967 | regulation of hydrolase activity |
| GO:0090087 | 0.00414 | 1.97779 | 11 | 21 | 724 | regulation of peptide transport |
| GO:0010563 | 0.00414 | 2.15240 | 8 | 17 | 538 | negative regulation of phosphorus metabolic process |
| GO:0045936 | 0.00414 | 2.15240 | 8 | 17 | 538 | negative regulation of phosphate metabolic process |
| GO:0003416 | 0.00417 | 6.65618 | 1 | 4 | 43 | endochondral bone growth |
| GO:0070849 | 0.00417 | 6.65618 | 1 | 4 | 43 | response to epidermal growth factor |
| GO:0034367 | 0.00442 | 10.22693 | 0 | 3 | 22 | protein-containing complex remodeling |
| GO:0071711 | 0.00442 | 10.22693 | 0 | 3 | 22 | basement membrane organization |
| GO:0001523 | 0.00454 | 6.48949 | 1 | 4 | 44 | retinoid metabolic process |
| GO:0032147 | 0.00458 | 2.79742 | 4 | 10 | 244 | activation of protein kinase activity |
| GO:0051348 | 0.00458 | 2.79742 | 4 | 10 | 244 | negative regulation of transferase activity |
| GO:0051223 | 0.00465 | 1.99181 | 10 | 20 | 684 | regulation of protein transport |
| GO:0032347 | 0.00467 | 25.85085 | 0 | 2 | 7 | regulation of aldosterone biosynthetic process |
| GO:0035931 | 0.00467 | 25.85085 | 0 | 2 | 7 | mineralocorticoid secretion |
| GO:0035932 | 0.00467 | 25.85085 | 0 | 2 | 7 | aldosterone secretion |
| GO:0035989 | 0.00467 | 25.85085 | 0 | 2 | 7 | tendon development |
| GO:0061438 | 0.00467 | 25.85085 | 0 | 2 | 7 | renal system vasculature morphogenesis |
| GO:0061439 | 0.00467 | 25.85085 | 0 | 2 | 7 | kidney vasculature morphogenesis |
| GO:0072161 | 0.00467 | 25.85085 | 0 | 2 | 7 | mesenchymal cell differentiation involved in kidney development |
| GO:0097048 | 0.00467 | 25.85085 | 0 | 2 | 7 | dendritic cell apoptotic process |
| GO:1900019 | 0.00467 | 25.85085 | 0 | 2 | 7 | regulation of protein kinase C activity |
| GO:1900020 | 0.00467 | 25.85085 | 0 | 2 | 7 | positive regulation of protein kinase C activity |
| GO:1901341 | 0.00467 | 25.85085 | 0 | 2 | 7 | positive regulation of store-operated calcium channel activity |
| GO:2000668 | 0.00467 | 25.85085 | 0 | 2 | 7 | regulation of dendritic cell apoptotic process |
| GO:2000855 | 0.00467 | 25.85085 | 0 | 2 | 7 | regulation of mineralocorticoid secretion |
| GO:2000858 | 0.00467 | 25.85085 | 0 | 2 | 7 | regulation of aldosterone secretion |
| GO:2001012 | 0.00467 | 25.85085 | 0 | 2 | 7 | mesenchymal cell differentiation involved in renal system development |
| GO:0019538 | 0.00475 | 1.37722 | 81 | 102 | 5268 | protein metabolic process |
| GO:0003014 | 0.00487 | 4.06911 | 2 | 6 | 102 | renal system process |
| GO:0032231 | 0.00487 | 4.06911 | 2 | 6 | 102 | regulation of actin filament bundle assembly |
| GO:0032965 | 0.00492 | 6.33093 | 1 | 4 | 45 | regulation of collagen biosynthetic process |
| GO:0098868 | 0.00492 | 6.33093 | 1 | 4 | 45 | bone growth |
| GO:0002376 | 0.00495 | 1.50034 | 40 | 56 | 2588 | immune system process |
| GO:0007423 | 0.00495 | 2.06241 | 9 | 18 | 594 | sensory organ development |
| GO:0060191 | 0.00496 | 4.85096 | 1 | 5 | 72 | regulation of lipase activity |
| GO:0030041 | 0.00498 | 3.20429 | 3 | 8 | 171 | actin filament polymerization |
| GO:0006631 | 0.00502 | 2.38468 | 6 | 13 | 371 | fatty acid metabolic process |
| GO:0032928 | 0.00503 | 9.71516 | 0 | 3 | 23 | regulation of superoxide anion generation |
| GO:0035455 | 0.00503 | 9.71516 | 0 | 3 | 23 | response to interferon-alpha |
| GO:0099149 | 0.00503 | 9.71516 | 0 | 3 | 23 | regulation of postsynaptic neurotransmitter receptor internalization |
| GO:0031098 | 0.00510 | 2.60206 | 4 | 11 | 288 | stress-activated protein kinase signaling cascade |
| GO:0032271 | 0.00510 | 2.94160 | 3 | 9 | 209 | regulation of protein polymerization |
| GO:0051048 | 0.00513 | 2.74991 | 4 | 10 | 248 | negative regulation of secretion |
| GO:0006109 | 0.00515 | 3.18461 | 3 | 8 | 172 | regulation of carbohydrate metabolic process |
| GO:0033036 | 0.00524 | 1.47728 | 43 | 60 | 2821 | macromolecule localization |
| GO:0035270 | 0.00526 | 3.51049 | 2 | 7 | 137 | endocrine system development |
| GO:0048844 | 0.00526 | 4.77941 | 1 | 5 | 73 | artery morphogenesis |
| GO:0033673 | 0.00526 | 2.92684 | 3 | 9 | 210 | negative regulation of kinase activity |
| GO:0071310 | 0.00527 | 1.51610 | 36 | 52 | 2372 | cellular response to organic substance |
| GO:0016101 | 0.00532 | 6.17992 | 1 | 4 | 46 | diterpenoid metabolic process |
| GO:0048536 | 0.00532 | 6.17992 | 1 | 4 | 46 | spleen development |
| GO:0032787 | 0.00533 | 2.09476 | 8 | 17 | 552 | monocarboxylic acid metabolic process |
| GO:0009612 | 0.00533 | 3.16517 | 3 | 8 | 173 | response to mechanical stimulus |
| GO:0043266 | 0.00535 | 3.98571 | 2 | 6 | 104 | regulation of potassium ion transport |
| GO:1903827 | 0.00539 | 2.14611 | 8 | 16 | 507 | regulation of cellular protein localization |
| GO:0009889 | 0.00542 | 1.43498 | 53 | 71 | 3456 | regulation of biosynthetic process |
| GO:0006464 | 0.00549 | 1.43715 | 52 | 70 | 3400 | cellular protein modification process |
| GO:0036211 | 0.00549 | 1.43715 | 52 | 70 | 3400 | protein modification process |
| GO:0051047 | 0.00549 | 2.14165 | 8 | 16 | 508 | positive regulation of secretion |
| GO:0022604 | 0.00559 | 2.13722 | 8 | 16 | 509 | regulation of cell morphogenesis |
| GO:0014896 | 0.00560 | 3.94528 | 2 | 6 | 105 | muscle hypertrophy |
| GO:0048661 | 0.00560 | 3.94528 | 2 | 6 | 105 | positive regulation of smooth muscle cell proliferation |
| GO:0032880 | 0.00564 | 1.78951 | 15 | 26 | 991 | regulation of protein localization |
| GO:0009065 | 0.00568 | 9.25212 | 0 | 3 | 24 | glutamine family amino acid catabolic process |
| GO:0042474 | 0.00568 | 9.25212 | 0 | 3 | 24 | middle ear morphogenesis |
| GO:0044342 | 0.00568 | 9.25212 | 0 | 3 | 24 | type B pancreatic cell proliferation |
| GO:0007267 | 0.00573 | 1.62329 | 24 | 37 | 1563 | cell-cell signaling |
| GO:0048762 | 0.00576 | 2.88341 | 3 | 9 | 213 | mesenchymal cell differentiation |
| GO:0009991 | 0.00610 | 2.32528 | 6 | 13 | 380 | response to extracellular stimulus |
| GO:0050808 | 0.00613 | 2.24377 | 6 | 14 | 424 | synapse organization |
| GO:0001935 | 0.00614 | 3.40510 | 2 | 7 | 141 | endothelial cell proliferation |
| GO:1903530 | 0.00616 | 1.87398 | 12 | 22 | 799 | regulation of secretion by cell |
| GO:0015911 | 0.00616 | 21.54143 | 0 | 2 | 8 | plasma membrane long-chain fatty acid transport |
| GO:0030214 | 0.00616 | 21.54143 | 0 | 2 | 8 | hyaluronan catabolic process |
| GO:0032344 | 0.00616 | 21.54143 | 0 | 2 | 8 | regulation of aldosterone metabolic process |
| GO:1900454 | 0.00616 | 21.54143 | 0 | 2 | 8 | positive regulation of long-term synaptic depression |
| GO:1902001 | 0.00616 | 21.54143 | 0 | 2 | 8 | fatty acid transmembrane transport |
| GO:2000543 | 0.00616 | 21.54143 | 0 | 2 | 8 | positive regulation of gastrulation |
| GO:0010862 | 0.00620 | 5.89850 | 1 | 4 | 48 | positive regulation of pathway-restricted SMAD protein phosphorylation |
| GO:0032330 | 0.00620 | 5.89850 | 1 | 4 | 48 | regulation of chondrocyte differentiation |
| GO:1902930 | 0.00620 | 5.89850 | 1 | 4 | 48 | regulation of alcohol biosynthetic process |
| GO:2001239 | 0.00620 | 5.89850 | 1 | 4 | 48 | regulation of extrinsic apoptotic signaling pathway in absence of ligand |
| GO:0051403 | 0.00620 | 2.67052 | 4 | 10 | 255 | stress-activated MAPK cascade |
| GO:0090596 | 0.00623 | 2.52813 | 5 | 11 | 296 | sensory organ morphogenesis |
| GO:0043010 | 0.00623 | 2.41372 | 5 | 12 | 338 | camera-type eye development |
| GO:1904427 | 0.00624 | 4.57686 | 1 | 5 | 76 | positive regulation of calcium ion transmembrane transport |
| GO:0042692 | 0.00637 | 2.31247 | 6 | 13 | 382 | muscle cell differentiation |
| GO:0002335 | 0.00639 | 8.83119 | 0 | 3 | 25 | mature B cell differentiation |
| GO:2000050 | 0.00639 | 8.83119 | 0 | 3 | 25 | regulation of non-canonical Wnt signaling pathway |
| GO:0044260 | 0.00640 | 1.33150 | 107 | 129 | 6974 | cellular macromolecule metabolic process |
| GO:0015844 | 0.00641 | 3.82874 | 2 | 6 | 108 | monoamine transport |
| GO:1904019 | 0.00641 | 3.82874 | 2 | 6 | 108 | epithelial cell apoptotic process |
| GO:0051248 | 0.00642 | 1.75007 | 16 | 27 | 1052 | negative regulation of protein metabolic process |
| GO:0071495 | 0.00650 | 1.69710 | 18 | 30 | 1207 | cellular response to endogenous stimulus |
| GO:0050807 | 0.00654 | 2.64866 | 4 | 10 | 257 | regulation of synapse organization |
| GO:1903317 | 0.00659 | 4.51310 | 1 | 5 | 77 | regulation of protein maturation |
| GO:0072073 | 0.00661 | 3.35473 | 2 | 7 | 143 | kidney epithelium development |
| GO:0006749 | 0.00667 | 5.76717 | 1 | 4 | 49 | glutathione metabolic process |
| GO:0032941 | 0.00667 | 5.76717 | 1 | 4 | 49 | secretion by tissue |
| GO:0072009 | 0.00670 | 3.79140 | 2 | 6 | 109 | nephron epithelium development |
| GO:0045766 | 0.00673 | 3.03542 | 3 | 8 | 180 | positive regulation of angiogenesis |
| GO:0045765 | 0.00686 | 2.49269 | 5 | 11 | 300 | regulation of angiogenesis |
| GO:0019318 | 0.00687 | 2.80029 | 3 | 9 | 219 | hexose metabolic process |
| GO:0030168 | 0.00695 | 4.45108 | 1 | 5 | 78 | platelet activation |
| GO:0060976 | 0.00695 | 4.45108 | 1 | 5 | 78 | coronary vasculature development |
| GO:0044267 | 0.00695 | 1.37700 | 69 | 88 | 4494 | cellular protein metabolic process |
| GO:0051146 | 0.00703 | 2.48399 | 5 | 11 | 301 | striated muscle cell differentiation |
| GO:0030098 | 0.00707 | 2.28104 | 6 | 13 | 387 | lymphocyte differentiation |
| GO:0060348 | 0.00707 | 2.78689 | 3 | 9 | 220 | bone development |
| GO:1903531 | 0.00707 | 2.78689 | 3 | 9 | 220 | negative regulation of secretion by cell |
| GO:0031295 | 0.00714 | 8.44685 | 0 | 3 | 26 | T cell costimulation |
| GO:0001654 | 0.00722 | 2.27486 | 6 | 13 | 388 | eye development |
| GO:0150063 | 0.00722 | 2.27486 | 6 | 13 | 388 | visual system development |
| GO:0006790 | 0.00726 | 2.60599 | 4 | 10 | 261 | sulfur compound metabolic process |
| GO:0010001 | 0.00727 | 2.77363 | 3 | 9 | 221 | glial cell differentiation |
| GO:0072329 | 0.00731 | 3.71886 | 2 | 6 | 111 | monocarboxylic acid catabolic process |
| GO:0038034 | 0.00733 | 4.39074 | 1 | 5 | 79 | signal transduction in absence of ligand |
| GO:0097192 | 0.00733 | 4.39074 | 1 | 5 | 79 | extrinsic apoptotic signaling pathway in absence of ligand |
| GO:0022612 | 0.00738 | 3.28189 | 2 | 7 | 146 | gland morphogenesis |
| GO:0045321 | 0.00739 | 1.76900 | 15 | 25 | 962 | leukocyte activation |
| GO:0009611 | 0.00742 | 2.12537 | 7 | 15 | 479 | response to wounding |
| GO:0071705 | 0.00747 | 1.52018 | 32 | 46 | 2081 | nitrogen compound transport |
| GO:0120036 | 0.00762 | 1.61168 | 23 | 35 | 1485 | plasma membrane bounded cell projection organization |
| GO:0001942 | 0.00762 | 3.68361 | 2 | 6 | 112 | hair follicle development |
| GO:0048880 | 0.00767 | 2.25651 | 6 | 13 | 391 | sensory system development |
| GO:0060351 | 0.00768 | 5.52128 | 1 | 4 | 51 | cartilage development involved in endochondral bone morphogenesis |
| GO:2000649 | 0.00768 | 5.52128 | 1 | 4 | 51 | regulation of sodium ion transmembrane transporter activity |
| GO:0030099 | 0.00783 | 2.25045 | 6 | 13 | 392 | myeloid cell differentiation |
| GO:0010692 | 0.00785 | 18.46328 | 0 | 2 | 9 | regulation of alkaline phosphatase activity |
| GO:0061004 | 0.00785 | 18.46328 | 0 | 2 | 9 | pattern specification involved in kidney development |
| GO:0072048 | 0.00785 | 18.46328 | 0 | 2 | 9 | renal system pattern specification |
| GO:1903800 | 0.00785 | 18.46328 | 0 | 2 | 9 | positive regulation of production of miRNAs involved in gene silencing by miRNA |
| GO:2000848 | 0.00785 | 18.46328 | 0 | 2 | 9 | positive regulation of corticosteroid hormone secretion |
| GO:0043412 | 0.00792 | 1.40447 | 55 | 72 | 3571 | macromolecule modification |
| GO:0008360 | 0.00793 | 3.23506 | 2 | 7 | 148 | regulation of cell shape |
| GO:0032891 | 0.00794 | 8.09455 | 0 | 3 | 27 | negative regulation of organic acid transport |
| GO:0045780 | 0.00794 | 8.09455 | 0 | 3 | 27 | positive regulation of bone resorption |
| GO:0046852 | 0.00794 | 8.09455 | 0 | 3 | 27 | positive regulation of bone remodeling |
| GO:0097345 | 0.00794 | 8.09455 | 0 | 3 | 27 | mitochondrial outer membrane permeabilization |
| GO:0007169 | 0.00810 | 2.04797 | 8 | 16 | 530 | transmembrane receptor protein tyrosine kinase signaling pathway |
| GO:0030203 | 0.00813 | 4.27482 | 1 | 5 | 81 | glycosaminoglycan metabolic process |
| GO:0019637 | 0.00821 | 1.77391 | 14 | 24 | 920 | organophosphate metabolic process |
| GO:0010712 | 0.00822 | 5.40601 | 1 | 4 | 52 | regulation of collagen metabolic process |
| GO:0045773 | 0.00822 | 5.40601 | 1 | 4 | 52 | positive regulation of axon extension |
| GO:2000351 | 0.00822 | 5.40601 | 1 | 4 | 52 | regulation of endothelial cell apoptotic process |
| GO:0002040 | 0.00828 | 3.61508 | 2 | 6 | 114 | sprouting angiogenesis |
| GO:0098773 | 0.00828 | 3.61508 | 2 | 6 | 114 | skin epidermis development |
| GO:0022404 | 0.00863 | 3.58176 | 2 | 6 | 115 | molting cycle process |
| GO:0022405 | 0.00863 | 3.58176 | 2 | 6 | 115 | hair cycle process |
| GO:0051235 | 0.00867 | 2.40826 | 5 | 11 | 310 | maintenance of location |
| GO:0006721 | 0.00879 | 5.29545 | 1 | 4 | 53 | terpenoid metabolic process |
| GO:0032350 | 0.00879 | 5.29545 | 1 | 4 | 53 | regulation of hormone metabolic process |
| GO:0046718 | 0.00879 | 5.29545 | 1 | 4 | 53 | viral entry into host cell |
| GO:0006929 | 0.00879 | 7.77042 | 0 | 3 | 28 | substrate-dependent cell migration |
| GO:0015991 | 0.00879 | 7.77042 | 0 | 3 | 28 | ATP hydrolysis coupled proton transport |
| GO:0031294 | 0.00879 | 7.77042 | 0 | 3 | 28 | lymphocyte costimulation |
| GO:0051589 | 0.00879 | 7.77042 | 0 | 3 | 28 | negative regulation of neurotransmitter transport |
| GO:1903319 | 0.00879 | 7.77042 | 0 | 3 | 28 | positive regulation of protein maturation |
| GO:0032940 | 0.00887 | 1.72052 | 16 | 26 | 1028 | secretion by cell |
| GO:0010906 | 0.00899 | 3.54904 | 2 | 6 | 116 | regulation of glucose metabolic process |
| GO:0044087 | 0.00908 | 1.75757 | 14 | 24 | 928 | regulation of cellular component biogenesis |
| GO:0009790 | 0.00916 | 1.66532 | 18 | 29 | 1186 | embryo development |
| GO:0042326 | 0.00917 | 2.13245 | 7 | 14 | 445 | negative regulation of phosphorylation |
| GO:0032872 | 0.00932 | 2.65962 | 4 | 9 | 230 | regulation of stress-activated MAPK cascade |
| GO:0032964 | 0.00938 | 5.18932 | 1 | 4 | 54 | collagen biosynthetic process |
| GO:0030307 | 0.00947 | 2.85158 | 3 | 8 | 191 | positive regulation of cell growth |
| GO:0045596 | 0.00947 | 1.82476 | 12 | 21 | 781 | negative regulation of cell differentiation |
| GO:0001958 | 0.00970 | 7.47124 | 0 | 3 | 29 | endochondral ossification |
| GO:0036075 | 0.00970 | 7.47124 | 0 | 3 | 29 | replacement ossification |
| GO:0061037 | 0.00970 | 7.47124 | 0 | 3 | 29 | negative regulation of cartilage development |
| GO:2000191 | 0.00970 | 7.47124 | 0 | 3 | 29 | regulation of fatty acid transport |
| GO:0031274 | 0.00971 | 16.15466 | 0 | 2 | 10 | positive regulation of pseudopodium assembly |
| GO:0032342 | 0.00971 | 16.15466 | 0 | 2 | 10 | aldosterone biosynthetic process |
| GO:0051823 | 0.00971 | 16.15466 | 0 | 2 | 10 | regulation of synapse structural plasticity |
| GO:0061626 | 0.00971 | 16.15466 | 0 | 2 | 10 | pharyngeal arch artery morphogenesis |
| GO:0072203 | 0.00971 | 16.15466 | 0 | 2 | 10 | cell proliferation involved in metanephros development |
| GO:1901339 | 0.00971 | 16.15466 | 0 | 2 | 10 | regulation of store-operated calcium channel activity |
| GO:0010565 | 0.00973 | 3.48536 | 2 | 6 | 118 | regulation of cellular ketone metabolic process |
| GO:1902905 | 0.00975 | 2.83596 | 3 | 8 | 192 | positive regulation of supramolecular fiber organization |
| GO:0006813 | 0.00982 | 2.63553 | 4 | 9 | 232 | potassium ion transport |
| GO:0070302 | 0.00982 | 2.63553 | 4 | 9 | 232 | regulation of stress-activated protein kinase signaling cascade |
| GO:0014032 | 0.00991 | 4.06036 | 1 | 5 | 85 | neural crest cell development |
| GO:1904035 | 0.00991 | 4.06036 | 1 | 5 | 85 | regulation of epithelial cell apoptotic process |
| GO:0035567 | 0.01000 | 5.08734 | 1 | 4 | 55 | non-canonical Wnt signaling pathway |
| GO:0072577 | 0.01000 | 5.08734 | 1 | 4 | 55 | endothelial cell apoptotic process |
| GO:0071496 | 0.01026 | 2.46679 | 4 | 10 | 275 | cellular response to external stimulus |
| GO:0043542 | 0.01034 | 2.80522 | 3 | 8 | 194 | endothelial cell migration |
| GO:0002009 | 0.01056 | 1.98473 | 8 | 16 | 546 | morphogenesis of an epithelium |
| GO:1903532 | 0.01060 | 2.09285 | 7 | 14 | 453 | positive regulation of secretion by cell |
| GO:0007588 | 0.01064 | 4.98929 | 1 | 4 | 56 | excretion |
| GO:0030260 | 0.01064 | 4.98929 | 1 | 4 | 56 | entry into host cell |
| GO:0044409 | 0.01064 | 4.98929 | 1 | 4 | 56 | entry into host |
| GO:0051806 | 0.01064 | 4.98929 | 1 | 4 | 56 | entry into cell of other organism involved in symbiotic interaction |
| GO:0051828 | 0.01064 | 4.98929 | 1 | 4 | 56 | entry into other organism involved in symbiotic interaction |
| GO:0032232 | 0.01066 | 7.19421 | 0 | 3 | 30 | negative regulation of actin filament bundle assembly |
| GO:0032958 | 0.01066 | 7.19421 | 0 | 3 | 30 | inositol phosphate biosynthetic process |
| GO:0061036 | 0.01066 | 7.19421 | 0 | 3 | 30 | positive regulation of cartilage development |
| GO:0090662 | 0.01066 | 7.19421 | 0 | 3 | 30 | ATP hydrolysis coupled transmembrane transport |
| GO:0099131 | 0.01066 | 7.19421 | 0 | 3 | 30 | ATP hydrolysis coupled ion transmembrane transport |
| GO:0099132 | 0.01066 | 7.19421 | 0 | 3 | 30 | ATP hydrolysis coupled cation transmembrane transport |
| GO:1902110 | 0.01066 | 7.19421 | 0 | 3 | 30 | positive regulation of mitochondrial membrane permeability involved in apoptotic process |
| GO:0031328 | 0.01074 | 1.51811 | 28 | 41 | 1848 | positive regulation of cellular biosynthetic process |
| GO:0007596 | 0.01077 | 3.03975 | 2 | 7 | 157 | blood coagulation |
| GO:0002683 | 0.01079 | 2.08800 | 7 | 14 | 454 | negative regulation of immune system process |
| GO:1901362 | 0.01079 | 1.38965 | 53 | 69 | 3444 | organic cyclic compound biosynthetic process |
| GO:0031175 | 0.01092 | 1.68876 | 16 | 26 | 1046 | neuron projection development |
| GO:0043112 | 0.01095 | 2.77513 | 3 | 8 | 196 | receptor metabolic process |
| GO:2001257 | 0.01113 | 3.01949 | 2 | 7 | 158 | regulation of cation channel activity |
| GO:0006954 | 0.01124 | 1.88723 | 10 | 18 | 646 | inflammatory response |
| GO:1903510 | 0.01131 | 4.89494 | 1 | 4 | 57 | mucopolysaccharide metabolic process |
| GO:0046165 | 0.01135 | 3.36458 | 2 | 6 | 122 | alcohol biosynthetic process |
| GO:0033077 | 0.01141 | 3.91309 | 1 | 5 | 88 | T cell differentiation in thymus |
| GO:0007599 | 0.01149 | 2.99949 | 2 | 7 | 159 | hemostasis |
| GO:0033554 | 0.01158 | 1.53374 | 26 | 38 | 1692 | cellular response to stress |
| GO:0032967 | 0.01167 | 6.93697 | 0 | 3 | 31 | positive regulation of collagen biosynthetic process |
| GO:0098884 | 0.01167 | 6.93697 | 0 | 3 | 31 | postsynaptic neurotransmitter receptor internalization |
| GO:0140239 | 0.01167 | 6.93697 | 0 | 3 | 31 | postsynaptic endocytosis |
| GO:0006705 | 0.01175 | 14.35907 | 0 | 2 | 11 | mineralocorticoid biosynthetic process |
| GO:0031272 | 0.01175 | 14.35907 | 0 | 2 | 11 | regulation of pseudopodium assembly |
| GO:0032026 | 0.01175 | 14.35907 | 0 | 2 | 11 | response to magnesium ion |
| GO:0032341 | 0.01175 | 14.35907 | 0 | 2 | 11 | aldosterone metabolic process |
| GO:0032464 | 0.01175 | 14.35907 | 0 | 2 | 11 | positive regulation of protein homooligomerization |
| GO:0032486 | 0.01175 | 14.35907 | 0 | 2 | 11 | Rap protein signal transduction |
| GO:0032959 | 0.01175 | 14.35907 | 0 | 2 | 11 | inositol trisphosphate biosynthetic process |
| GO:0033539 | 0.01175 | 14.35907 | 0 | 2 | 11 | fatty acid beta-oxidation using acyl-CoA dehydrogenase |
| GO:0033603 | 0.01175 | 14.35907 | 0 | 2 | 11 | positive regulation of dopamine secretion |
| GO:0034375 | 0.01175 | 14.35907 | 0 | 2 | 11 | high-density lipoprotein particle remodeling |
| GO:0043568 | 0.01175 | 14.35907 | 0 | 2 | 11 | positive regulation of insulin-like growth factor receptor signaling pathway |
| GO:0043652 | 0.01175 | 14.35907 | 0 | 2 | 11 | engulfment of apoptotic cell |
| GO:0071732 | 0.01175 | 14.35907 | 0 | 2 | 11 | cellular response to nitric oxide |
| GO:0051259 | 0.01182 | 1.91479 | 9 | 17 | 601 | protein complex oligomerization |
| GO:0030030 | 0.01182 | 1.55877 | 23 | 35 | 1531 | cell projection organization |
| GO:0034446 | 0.01194 | 3.86633 | 1 | 5 | 89 | substrate adhesion-dependent cell spreading |
| GO:0060395 | 0.01194 | 3.86633 | 1 | 5 | 89 | SMAD protein signal transduction |
| GO:0006874 | 0.01199 | 2.05936 | 7 | 14 | 460 | cellular calcium ion homeostasis |
| GO:0010557 | 0.01211 | 1.52044 | 27 | 39 | 1752 | positive regulation of macromolecule biosynthetic process |
| GO:0030177 | 0.01223 | 3.30726 | 2 | 6 | 124 | positive regulation of Wnt signaling pathway |
| GO:0050817 | 0.01225 | 2.96028 | 2 | 7 | 161 | coagulation |
| GO:0071560 | 0.01226 | 2.71683 | 3 | 8 | 200 | cellular response to transforming growth factor beta stimulus |
| GO:0014031 | 0.01249 | 3.82068 | 1 | 5 | 90 | mesenchymal cell development |
| GO:0046889 | 0.01249 | 3.82068 | 1 | 5 | 90 | positive regulation of lipid biosynthetic process |
| GO:1902600 | 0.01249 | 3.82068 | 1 | 5 | 90 | proton transmembrane transport |
| GO:0046890 | 0.01264 | 2.94105 | 2 | 7 | 162 | regulation of lipid biosynthetic process |
| GO:0048660 | 0.01264 | 2.94105 | 2 | 7 | 162 | regulation of smooth muscle cell proliferation |
| GO:0050710 | 0.01272 | 4.71653 | 1 | 4 | 59 | negative regulation of cytokine secretion |
| GO:0015988 | 0.01273 | 6.69747 | 0 | 3 | 32 | energy coupled proton transmembrane transport, against electrochemical gradient |
| GO:0042554 | 0.01273 | 6.69747 | 0 | 3 | 32 | superoxide anion generation |
| GO:0060977 | 0.01273 | 6.69747 | 0 | 3 | 32 | coronary vasculature morphogenesis |
| GO:1902686 | 0.01273 | 6.69747 | 0 | 3 | 32 | mitochondrial outer membrane permeabilization involved in programmed cell death |
| GO:0051017 | 0.01304 | 2.92207 | 2 | 7 | 163 | actin filament bundle assembly |
| GO:0002028 | 0.01305 | 3.77609 | 1 | 5 | 91 | regulation of sodium ion transport |
| GO:0048864 | 0.01305 | 3.77609 | 1 | 5 | 91 | stem cell development |
| GO:0006897 | 0.01311 | 1.82155 | 11 | 19 | 706 | endocytosis |
| GO:0098609 | 0.01329 | 1.81882 | 11 | 19 | 707 | cell-cell adhesion |
| GO:0097164 | 0.01344 | 2.90333 | 3 | 7 | 164 | ammonium ion metabolic process |
| GO:1902105 | 0.01352 | 2.35867 | 4 | 10 | 287 | regulation of leukocyte differentiation |
| GO:0014033 | 0.01363 | 3.73252 | 1 | 5 | 92 | neural crest cell differentiation |
| GO:0001936 | 0.01364 | 3.22484 | 2 | 6 | 127 | regulation of endothelial cell proliferation |
| GO:0046596 | 0.01385 | 6.47394 | 1 | 3 | 33 | regulation of viral entry into host cell |
| GO:0060292 | 0.01385 | 6.47394 | 1 | 3 | 33 | long-term synaptic depression |
| GO:0071827 | 0.01385 | 6.47394 | 1 | 3 | 33 | plasma lipoprotein particle organization |
| GO:0090322 | 0.01385 | 6.47394 | 1 | 3 | 33 | regulation of superoxide metabolic process |
| GO:0140115 | 0.01385 | 6.47394 | 1 | 3 | 33 | export across plasma membrane |
| GO:2000249 | 0.01385 | 6.47394 | 1 | 3 | 33 | regulation of actin cytoskeleton reorganization |
| GO:0008212 | 0.01395 | 12.92260 | 0 | 2 | 12 | mineralocorticoid metabolic process |
| GO:0009437 | 0.01395 | 12.92260 | 0 | 2 | 12 | carnitine metabolic process |
| GO:0010749 | 0.01395 | 12.92260 | 0 | 2 | 12 | regulation of nitric oxide mediated signal transduction |
| GO:0021670 | 0.01395 | 12.92260 | 0 | 2 | 12 | lateral ventricle development |
| GO:0032488 | 0.01395 | 12.92260 | 0 | 2 | 12 | Cdc42 protein signal transduction |
| GO:0032825 | 0.01395 | 12.92260 | 0 | 2 | 12 | positive regulation of natural killer cell differentiation |
| GO:0034309 | 0.01395 | 12.92260 | 0 | 2 | 12 | primary alcohol biosynthetic process |
| GO:0046929 | 0.01395 | 12.92260 | 0 | 2 | 12 | negative regulation of neurotransmitter secretion |
| GO:0060068 | 0.01395 | 12.92260 | 0 | 2 | 12 | vagina development |
| GO:0072110 | 0.01395 | 12.92260 | 0 | 2 | 12 | glomerular mesangial cell proliferation |
| GO:1902430 | 0.01395 | 12.92260 | 0 | 2 | 12 | negative regulation of amyloid-beta formation |
| GO:1903961 | 0.01395 | 12.92260 | 0 | 2 | 12 | positive regulation of anion transmembrane transport |
| GO:0009892 | 0.01400 | 1.40728 | 43 | 57 | 2787 | negative regulation of metabolic process |
| GO:0071559 | 0.01405 | 2.64730 | 3 | 8 | 205 | response to transforming growth factor beta |
| GO:0009062 | 0.01423 | 3.68994 | 1 | 5 | 93 | fatty acid catabolic process |
| GO:0043506 | 0.01423 | 3.68994 | 1 | 5 | 93 | regulation of JUN kinase activity |
| GO:0090263 | 0.01423 | 3.68994 | 1 | 5 | 93 | positive regulation of canonical Wnt signaling pathway |
| GO:1902305 | 0.01425 | 4.55064 | 1 | 4 | 61 | regulation of sodium ion transmembrane transport |
| GO:0018130 | 0.01426 | 1.37631 | 51 | 66 | 3313 | heterocycle biosynthetic process |
| GO:0010821 | 0.01463 | 3.17213 | 2 | 6 | 129 | regulation of mitochondrion organization |
| GO:0030218 | 0.01463 | 3.17213 | 2 | 6 | 129 | erythrocyte differentiation |
| GO:0045995 | 0.01463 | 3.17213 | 2 | 6 | 129 | regulation of embryonic development |
| GO:0048659 | 0.01472 | 2.84851 | 3 | 7 | 167 | smooth muscle cell proliferation |
| GO:0030279 | 0.01485 | 3.64832 | 1 | 5 | 94 | negative regulation of ossification |
| GO:0048871 | 0.01494 | 1.99987 | 7 | 14 | 473 | multicellular organismal homeostasis |
| GO:0010714 | 0.01502 | 6.26483 | 1 | 3 | 34 | positive regulation of collagen metabolic process |
| GO:0038084 | 0.01502 | 6.26483 | 1 | 3 | 34 | vascular endothelial growth factor signaling pathway |
| GO:1904037 | 0.01502 | 6.26483 | 1 | 3 | 34 | positive regulation of epithelial cell apoptotic process |
| GO:0005996 | 0.01502 | 2.44701 | 4 | 9 | 249 | monosaccharide metabolic process |
| GO:0060393 | 0.01505 | 4.47198 | 1 | 4 | 62 | regulation of pathway-restricted SMAD protein phosphorylation |
| GO:0070098 | 0.01505 | 4.47198 | 1 | 4 | 62 | chemokine-mediated signaling pathway |
| GO:0048666 | 0.01510 | 1.60885 | 18 | 28 | 1181 | neuron development |
| GO:0048699 | 0.01511 | 1.51993 | 25 | 36 | 1613 | generation of neurons |
| GO:0002316 | 0.01532 | Inf | 0 | 1 | 1 | follicular B cell differentiation |
| GO:0002605 | 0.01532 | Inf | 0 | 1 | 1 | negative regulation of dendritic cell antigen processing and presentation |
| GO:0003083 | 0.01532 | Inf | 0 | 1 | 1 | negative regulation of renal output by angiotensin |
| GO:0003106 | 0.01532 | Inf | 0 | 1 | 1 | negative regulation of glomerular filtration by angiotensin |
| GO:0003243 | 0.01532 | Inf | 0 | 1 | 1 | circumferential growth involved in left ventricle morphogenesis |
| GO:0006050 | 0.01532 | Inf | 0 | 1 | 1 | mannosamine metabolic process |
| GO:0006051 | 0.01532 | Inf | 0 | 1 | 1 | N-acetylmannosamine metabolic process |
| GO:0006062 | 0.01532 | Inf | 0 | 1 | 1 | sorbitol catabolic process |
| GO:0006539 | 0.01532 | Inf | 0 | 1 | 1 | glutamate catabolic process via 2-oxoglutarate |
| GO:0007500 | 0.01532 | Inf | 0 | 1 | 1 | mesodermal cell fate determination |
| GO:0010189 | 0.01532 | Inf | 0 | 1 | 1 | vitamin E biosynthetic process |
| GO:0014895 | 0.01532 | Inf | 0 | 1 | 1 | smooth muscle hypertrophy |
| GO:0016243 | 0.01532 | Inf | 0 | 1 | 1 | regulation of autophagosome size |
| GO:0018217 | 0.01532 | Inf | 0 | 1 | 1 | peptidyl-aspartic acid phosphorylation |
| GO:0019285 | 0.01532 | Inf | 0 | 1 | 1 | glycine betaine biosynthetic process from choline |
| GO:0019407 | 0.01532 | Inf | 0 | 1 | 1 | hexitol catabolic process |
| GO:0019519 | 0.01532 | Inf | 0 | 1 | 1 | pentitol metabolic process |
| GO:0019527 | 0.01532 | Inf | 0 | 1 | 1 | pentitol catabolic process |
| GO:0021572 | 0.01532 | Inf | 0 | 1 | 1 | rhombomere 6 development |
| GO:0031455 | 0.01532 | Inf | 0 | 1 | 1 | glycine betaine metabolic process |
| GO:0031456 | 0.01532 | Inf | 0 | 1 | 1 | glycine betaine biosynthetic process |
| GO:0033366 | 0.01532 | Inf | 0 | 1 | 1 | protein localization to secretory granule |
| GO:0033367 | 0.01532 | Inf | 0 | 1 | 1 | protein localization to mast cell secretory granule |
| GO:0033368 | 0.01532 | Inf | 0 | 1 | 1 | protease localization to mast cell secretory granule |
| GO:0033370 | 0.01532 | Inf | 0 | 1 | 1 | maintenance of protein location in mast cell secretory granule |
| GO:0033371 | 0.01532 | Inf | 0 | 1 | 1 | T cell secretory granule organization |
| GO:0033373 | 0.01532 | Inf | 0 | 1 | 1 | maintenance of protease location in mast cell secretory granule |
| GO:0033374 | 0.01532 | Inf | 0 | 1 | 1 | protein localization to T cell secretory granule |
| GO:0033375 | 0.01532 | Inf | 0 | 1 | 1 | protease localization to T cell secretory granule |
| GO:0033377 | 0.01532 | Inf | 0 | 1 | 1 | maintenance of protein location in T cell secretory granule |
| GO:0033379 | 0.01532 | Inf | 0 | 1 | 1 | maintenance of protease location in T cell secretory granule |
| GO:0033380 | 0.01532 | Inf | 0 | 1 | 1 | granzyme B localization to T cell secretory granule |
| GO:0033382 | 0.01532 | Inf | 0 | 1 | 1 | maintenance of granzyme B location in T cell secretory granule |
| GO:0034120 | 0.01532 | Inf | 0 | 1 | 1 | positive regulation of erythrocyte aggregation |
| GO:0035378 | 0.01532 | Inf | 0 | 1 | 1 | carbon dioxide transmembrane transport |
| GO:0035407 | 0.01532 | Inf | 0 | 1 | 1 | histone H3-T11 phosphorylation |
| GO:0035589 | 0.01532 | Inf | 0 | 1 | 1 | G protein-coupled purinergic nucleotide receptor signaling pathway |
| GO:0035971 | 0.01532 | Inf | 0 | 1 | 1 | peptidyl-histidine dephosphorylation |
| GO:0043095 | 0.01532 | Inf | 0 | 1 | 1 | regulation of GTP cyclohydrolase I activity |
| GO:0043105 | 0.01532 | Inf | 0 | 1 | 1 | negative regulation of GTP cyclohydrolase I activity |
| GO:0046491 | 0.01532 | Inf | 0 | 1 | 1 | L-methylmalonyl-CoA metabolic process |
| GO:0048390 | 0.01532 | Inf | 0 | 1 | 1 | intermediate mesoderm morphogenesis |
| GO:0048391 | 0.01532 | Inf | 0 | 1 | 1 | intermediate mesoderm formation |
| GO:0048392 | 0.01532 | Inf | 0 | 1 | 1 | intermediate mesodermal cell differentiation |
| GO:0051160 | 0.01532 | Inf | 0 | 1 | 1 | L-xylitol catabolic process |
| GO:0051164 | 0.01532 | Inf | 0 | 1 | 1 | L-xylitol metabolic process |
| GO:0055018 | 0.01532 | Inf | 0 | 1 | 1 | regulation of cardiac muscle fiber development |
| GO:0055020 | 0.01532 | Inf | 0 | 1 | 1 | positive regulation of cardiac muscle fiber development |
| GO:0060345 | 0.01532 | Inf | 0 | 1 | 1 | spleen trabecula formation |
| GO:0060503 | 0.01532 | Inf | 0 | 1 | 1 | bud dilation involved in lung branching |
| GO:0060981 | 0.01532 | Inf | 0 | 1 | 1 | cell migration involved in coronary angiogenesis |
| GO:0061149 | 0.01532 | Inf | 0 | 1 | 1 | BMP signaling pathway involved in ureter morphogenesis |
| GO:0061150 | 0.01532 | Inf | 0 | 1 | 1 | renal system segmentation |
| GO:0061151 | 0.01532 | Inf | 0 | 1 | 1 | BMP signaling pathway involved in renal system segmentation |
| GO:0061155 | 0.01532 | Inf | 0 | 1 | 1 | pulmonary artery endothelial tube morphogenesis |
| GO:0061163 | 0.01532 | Inf | 0 | 1 | 1 | endoplasmic reticulum polarization |
| GO:0061216 | 0.01532 | Inf | 0 | 1 | 1 | regulation of transcription from RNA polymerase II promoter involved in mesonephros development |
| GO:0061573 | 0.01532 | Inf | 0 | 1 | 1 | actin filament bundle retrograde transport |
| GO:0071893 | 0.01532 | Inf | 0 | 1 | 1 | BMP signaling pathway involved in nephric duct formation |
| GO:0072019 | 0.01532 | Inf | 0 | 1 | 1 | proximal convoluted tubule development |
| GO:0072020 | 0.01532 | Inf | 0 | 1 | 1 | proximal straight tubule development |
| GO:0072022 | 0.01532 | Inf | 0 | 1 | 1 | descending thin limb development |
| GO:0072032 | 0.01532 | Inf | 0 | 1 | 1 | proximal convoluted tubule segment 2 development |
| GO:0072096 | 0.01532 | Inf | 0 | 1 | 1 | negative regulation of branch elongation involved in ureteric bud branching |
| GO:0072097 | 0.01532 | Inf | 0 | 1 | 1 | negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway |
| GO:0072099 | 0.01532 | Inf | 0 | 1 | 1 | anterior/posterior pattern specification involved in ureteric bud development |
| GO:0072100 | 0.01532 | Inf | 0 | 1 | 1 | specification of ureteric bud anterior/posterior symmetry |
| GO:0072101 | 0.01532 | Inf | 0 | 1 | 1 | specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway |
| GO:0072165 | 0.01532 | Inf | 0 | 1 | 1 | anterior mesonephric tubule development |
| GO:0072167 | 0.01532 | Inf | 0 | 1 | 1 | specification of mesonephric tubule identity |
| GO:0072168 | 0.01532 | Inf | 0 | 1 | 1 | specification of anterior mesonephric tubule identity |
| GO:0072169 | 0.01532 | Inf | 0 | 1 | 1 | specification of posterior mesonephric tubule identity |
| GO:0072183 | 0.01532 | Inf | 0 | 1 | 1 | negative regulation of nephron tubule epithelial cell differentiation |
| GO:0072184 | 0.01532 | Inf | 0 | 1 | 1 | renal vesicle progenitor cell differentiation |
| GO:0072192 | 0.01532 | Inf | 0 | 1 | 1 | ureter epithelial cell differentiation |
| GO:0072200 | 0.01532 | Inf | 0 | 1 | 1 | negative regulation of mesenchymal cell proliferation involved in ureter development |
| GO:0072208 | 0.01532 | Inf | 0 | 1 | 1 | metanephric smooth muscle tissue development |
| GO:0072220 | 0.01532 | Inf | 0 | 1 | 1 | metanephric descending thin limb development |
| GO:0072229 | 0.01532 | Inf | 0 | 1 | 1 | metanephric proximal convoluted tubule development |
| GO:0072230 | 0.01532 | Inf | 0 | 1 | 1 | metanephric proximal straight tubule development |
| GO:0072232 | 0.01532 | Inf | 0 | 1 | 1 | metanephric proximal convoluted tubule segment 2 development |
| GO:0072237 | 0.01532 | Inf | 0 | 1 | 1 | metanephric proximal tubule development |
| GO:0072258 | 0.01532 | Inf | 0 | 1 | 1 | metanephric interstitial fibroblast differentiation |
| GO:0072259 | 0.01532 | Inf | 0 | 1 | 1 | metanephric interstitial fibroblast development |
| GO:0085018 | 0.01532 | Inf | 0 | 1 | 1 | maintenance of symbiont-containing vacuole by host |
| GO:0120179 | 0.01532 | Inf | 0 | 1 | 1 | adherens junction disassembly |
| GO:0120180 | 0.01532 | Inf | 0 | 1 | 1 | cell-substrate adherens junction disassembly |
| GO:0120181 | 0.01532 | Inf | 0 | 1 | 1 | focal adhesion disassembly |
| GO:0120182 | 0.01532 | Inf | 0 | 1 | 1 | regulation of focal adhesion disassembly |
| GO:0120183 | 0.01532 | Inf | 0 | 1 | 1 | positive regulation of focal adhesion disassembly |
| GO:1900276 | 0.01532 | Inf | 0 | 1 | 1 | regulation of proteinase activated receptor activity |
| GO:1900737 | 0.01532 | Inf | 0 | 1 | 1 | negative regulation of phospholipase C-activating G protein-coupled receptor signaling pathway |
| GO:1901964 | 0.01532 | Inf | 0 | 1 | 1 | positive regulation of cell proliferation involved in outflow tract morphogenesis |
| GO:1902769 | 0.01532 | Inf | 0 | 1 | 1 | regulation of choline O-acetyltransferase activity |
| GO:1902771 | 0.01532 | Inf | 0 | 1 | 1 | positive regulation of choline O-acetyltransferase activity |
| GO:1902948 | 0.01532 | Inf | 0 | 1 | 1 | negative regulation of tau-protein kinase activity |
| GO:1902955 | 0.01532 | Inf | 0 | 1 | 1 | positive regulation of early endosome to recycling endosome transport |
| GO:1902997 | 0.01532 | Inf | 0 | 1 | 1 | negative regulation of neurofibrillary tangle assembly |
| GO:1903048 | 0.01532 | Inf | 0 | 1 | 1 | regulation of acetylcholine-gated cation channel activity |
| GO:1903165 | 0.01532 | Inf | 0 | 1 | 1 | response to polycyclic arene |
| GO:1903166 | 0.01532 | Inf | 0 | 1 | 1 | cellular response to polycyclic arene |
| GO:1903414 | 0.01532 | Inf | 0 | 1 | 1 | iron cation export |
| GO:1903457 | 0.01532 | Inf | 0 | 1 | 1 | lactate catabolic process |
| GO:1903988 | 0.01532 | Inf | 0 | 1 | 1 | ferrous iron export across plasma membrane |
| GO:1904092 | 0.01532 | Inf | 0 | 1 | 1 | regulation of autophagic cell death |
| GO:1904093 | 0.01532 | Inf | 0 | 1 | 1 | negative regulation of autophagic cell death |
| GO:1904113 | 0.01532 | Inf | 0 | 1 | 1 | negative regulation of muscle filament sliding |
| GO:1904205 | 0.01532 | Inf | 0 | 1 | 1 | negative regulation of skeletal muscle hypertrophy |
| GO:1904242 | 0.01532 | Inf | 0 | 1 | 1 | regulation of pancreatic trypsinogen secretion |
| GO:1904244 | 0.01532 | Inf | 0 | 1 | 1 | positive regulation of pancreatic trypsinogen secretion |
| GO:1904451 | 0.01532 | Inf | 0 | 1 | 1 | regulation of potassium:proton exchanging ATPase activity |
| GO:1904453 | 0.01532 | Inf | 0 | 1 | 1 | positive regulation of potassium:proton exchanging ATPase activity |
| GO:1904621 | 0.01532 | Inf | 0 | 1 | 1 | regulation of actin-dependent ATPase activity |
| GO:1904622 | 0.01532 | Inf | 0 | 1 | 1 | negative regulation of actin-dependent ATPase activity |
| GO:1904681 | 0.01532 | Inf | 0 | 1 | 1 | response to 3-methylcholanthrene |
| GO:1904682 | 0.01532 | Inf | 0 | 1 | 1 | cellular response to 3-methylcholanthrene |
| GO:1990747 | 0.01532 | Inf | 0 | 1 | 1 | pancreatic trypsinogen secretion |
| GO:1990938 | 0.01532 | Inf | 0 | 1 | 1 | peptidyl-aspartic acid autophosphorylation |
| GO:1990953 | 0.01532 | Inf | 0 | 1 | 1 | intramanchette transport |
| GO:2000004 | 0.01532 | Inf | 0 | 1 | 1 | regulation of metanephric S-shaped body morphogenesis |
| GO:2000005 | 0.01532 | Inf | 0 | 1 | 1 | negative regulation of metanephric S-shaped body morphogenesis |
| GO:2000006 | 0.01532 | Inf | 0 | 1 | 1 | regulation of metanephric comma-shaped body morphogenesis |
| GO:2000007 | 0.01532 | Inf | 0 | 1 | 1 | negative regulation of metanephric comma-shaped body morphogenesis |
| GO:2000119 | 0.01532 | Inf | 0 | 1 | 1 | negative regulation of sodium-dependent phosphate transport |
| GO:2000446 | 0.01532 | Inf | 0 | 1 | 1 | regulation of macrophage migration inhibitory factor signaling pathway |
| GO:2000759 | 0.01532 | Inf | 0 | 1 | 1 | regulation of N-terminal peptidyl-lysine acetylation |
| GO:2000761 | 0.01532 | Inf | 0 | 1 | 1 | positive regulation of N-terminal peptidyl-lysine acetylation |
| GO:0022407 | 0.01537 | 2.12253 | 6 | 12 | 382 | regulation of cell-cell adhesion |
| GO:0051056 | 0.01538 | 2.43675 | 4 | 9 | 250 | regulation of small GTPase mediated signal transduction |
| GO:0050878 | 0.01539 | 2.20616 | 5 | 11 | 337 | regulation of body fluid levels |
| GO:0019722 | 0.01561 | 2.59416 | 3 | 8 | 209 | calcium-mediated signaling |
| GO:0043170 | 0.01572 | 1.27191 | 128 | 148 | 8357 | macromolecule metabolic process |
| GO:0046883 | 0.01574 | 2.29982 | 5 | 10 | 294 | regulation of hormone secretion |
| GO:0030595 | 0.01602 | 2.58120 | 3 | 8 | 210 | leukocyte chemotaxis |
| GO:0042221 | 0.01606 | 1.33870 | 62 | 78 | 4043 | response to chemical |
| GO:0043409 | 0.01609 | 2.79572 | 3 | 7 | 170 | negative regulation of MAPK cascade |
| GO:0042303 | 0.01622 | 3.09619 | 2 | 6 | 132 | molting cycle |
| GO:0042633 | 0.01622 | 3.09619 | 2 | 6 | 132 | hair cycle |
| GO:0035794 | 0.01624 | 6.06879 | 1 | 3 | 35 | positive regulation of mitochondrial membrane permeability |
| GO:0035909 | 0.01624 | 6.06879 | 1 | 3 | 35 | aorta morphogenesis |
| GO:0046329 | 0.01624 | 6.06879 | 1 | 3 | 35 | negative regulation of JNK cascade |
| GO:1900026 | 0.01624 | 6.06879 | 1 | 3 | 35 | positive regulation of substrate adhesion-dependent cell spreading |
| GO:0006122 | 0.01633 | 11.74730 | 0 | 2 | 13 | mitochondrial electron transport, ubiquinol to cytochrome c |
| GO:0010755 | 0.01633 | 11.74730 | 0 | 2 | 13 | regulation of plasminogen activation |
| GO:0031269 | 0.01633 | 11.74730 | 0 | 2 | 13 | pseudopodium assembly |
| GO:0042574 | 0.01633 | 11.74730 | 0 | 2 | 13 | retinal metabolic process |
| GO:0060391 | 0.01633 | 11.74730 | 0 | 2 | 13 | positive regulation of SMAD protein signal transduction |
| GO:0090331 | 0.01633 | 11.74730 | 0 | 2 | 13 | negative regulation of platelet aggregation |
| GO:1902170 | 0.01633 | 11.74730 | 0 | 2 | 13 | cellular response to reactive nitrogen species |
| GO:1903587 | 0.01633 | 11.74730 | 0 | 2 | 13 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis |
| GO:1903651 | 0.01633 | 11.74730 | 0 | 2 | 13 | positive regulation of cytoplasmic transport |
| GO:1905048 | 0.01633 | 11.74730 | 0 | 2 | 13 | regulation of metallopeptidase activity |
| GO:2000833 | 0.01633 | 11.74730 | 0 | 2 | 13 | positive regulation of steroid hormone secretion |
| GO:1901617 | 0.01644 | 2.56837 | 3 | 8 | 211 | organic hydroxy compound biosynthetic process |
| GO:0046649 | 0.01660 | 1.72146 | 13 | 21 | 825 | lymphocyte activation |
| GO:0048593 | 0.01678 | 3.07168 | 2 | 6 | 133 | camera-type eye morphogenesis |
| GO:0048675 | 0.01678 | 3.07168 | 2 | 6 | 133 | axon extension |
| GO:1901655 | 0.01678 | 3.07168 | 2 | 6 | 133 | cellular response to ketone |
| GO:0007584 | 0.01680 | 3.52889 | 1 | 5 | 97 | response to nutrient |
| GO:0019395 | 0.01680 | 3.52889 | 1 | 5 | 97 | fatty acid oxidation |
| GO:0072080 | 0.01680 | 3.52889 | 1 | 5 | 97 | nephron tubule development |
| GO:0050865 | 0.01686 | 1.80157 | 10 | 18 | 675 | regulation of cell activation |
| GO:0045944 | 0.01702 | 1.59140 | 18 | 28 | 1193 | positive regulation of transcription by RNA polymerase II |
| GO:1901575 | 0.01703 | 1.48202 | 27 | 39 | 1793 | organic substance catabolic process |
| GO:0048592 | 0.01705 | 2.76159 | 3 | 7 | 172 | eye morphogenesis |
| GO:0070887 | 0.01706 | 1.38304 | 45 | 59 | 2933 | cellular response to chemical stimulus |
| GO:0032101 | 0.01708 | 1.76843 | 11 | 19 | 726 | regulation of response to external stimulus |
| GO:0051129 | 0.01730 | 1.76585 | 11 | 19 | 727 | negative regulation of cellular component organization |
| GO:0034622 | 0.01740 | 1.65083 | 15 | 24 | 984 | cellular protein-containing complex assembly |
| GO:0031532 | 0.01749 | 3.49079 | 2 | 5 | 98 | actin cytoskeleton reorganization |
| GO:0043255 | 0.01749 | 3.49079 | 2 | 5 | 98 | regulation of carbohydrate biosynthetic process |
| GO:0043277 | 0.01752 | 5.88463 | 1 | 3 | 36 | apoptotic cell clearance |
| GO:0050919 | 0.01752 | 5.88463 | 1 | 3 | 36 | negative chemotaxis |
| GO:0051953 | 0.01752 | 5.88463 | 1 | 3 | 36 | negative regulation of amine transport |
| GO:0072503 | 0.01786 | 1.95211 | 7 | 14 | 484 | cellular divalent inorganic cation homeostasis |
| GO:0051495 | 0.01819 | 2.51830 | 3 | 8 | 215 | positive regulation of cytoskeleton organization |
| GO:0006022 | 0.01820 | 3.45351 | 2 | 5 | 99 | aminoglycan metabolic process |
| GO:0034440 | 0.01820 | 3.45351 | 2 | 5 | 99 | lipid oxidation |
| GO:0034599 | 0.01848 | 2.35763 | 4 | 9 | 258 | cellular response to oxidative stress |
| GO:0014068 | 0.01854 | 4.18273 | 1 | 4 | 66 | positive regulation of phosphatidylinositol 3-kinase signaling |
| GO:0060828 | 0.01864 | 2.50608 | 3 | 8 | 216 | regulation of canonical Wnt signaling pathway |
| GO:0043254 | 0.01885 | 1.99321 | 7 | 13 | 440 | regulation of protein complex assembly |
| GO:0007435 | 0.01885 | 5.71130 | 1 | 3 | 37 | salivary gland morphogenesis |
| GO:0030501 | 0.01885 | 5.71130 | 1 | 3 | 37 | positive regulation of bone mineralization |
| GO:0035850 | 0.01885 | 5.71130 | 1 | 3 | 37 | epithelial cell differentiation involved in kidney development |
| GO:0042398 | 0.01885 | 5.71130 | 1 | 3 | 37 | cellular modified amino acid biosynthetic process |
| GO:0048846 | 0.01885 | 5.71130 | 1 | 3 | 37 | axon extension involved in axon guidance |
| GO:0071825 | 0.01885 | 5.71130 | 1 | 3 | 37 | protein-lipid complex subunit organization |
| GO:1902108 | 0.01885 | 5.71130 | 1 | 3 | 37 | regulation of mitochondrial membrane permeability involved in apoptotic process |
| GO:1902284 | 0.01885 | 5.71130 | 1 | 3 | 37 | neuron projection extension involved in neuron projection guidance |
| GO:1905710 | 0.01885 | 5.71130 | 1 | 3 | 37 | positive regulation of membrane permeability |
| GO:0010839 | 0.01886 | 10.76789 | 0 | 2 | 14 | negative regulation of keratinocyte proliferation |
| GO:0014819 | 0.01886 | 10.76789 | 0 | 2 | 14 | regulation of skeletal muscle contraction |
| GO:0019370 | 0.01886 | 10.76789 | 0 | 2 | 14 | leukotriene biosynthetic process |
| GO:0030949 | 0.01886 | 10.76789 | 0 | 2 | 14 | positive regulation of vascular endothelial growth factor receptor signaling pathway |
| GO:0061318 | 0.01886 | 10.76789 | 0 | 2 | 14 | renal filtration cell differentiation |
| GO:0072112 | 0.01886 | 10.76789 | 0 | 2 | 14 | glomerular visceral epithelial cell differentiation |
| GO:0072311 | 0.01886 | 10.76789 | 0 | 2 | 14 | glomerular epithelial cell differentiation |
| GO:0090136 | 0.01886 | 10.76789 | 0 | 2 | 14 | epithelial cell-cell adhesion |
| GO:1902931 | 0.01886 | 10.76789 | 0 | 2 | 14 | negative regulation of alcohol biosynthetic process |
| GO:1902992 | 0.01886 | 10.76789 | 0 | 2 | 14 | negative regulation of amyloid precursor protein catabolic process |
| GO:0006029 | 0.01949 | 4.11616 | 1 | 4 | 67 | proteoglycan metabolic process |
| GO:0006635 | 0.01949 | 4.11616 | 1 | 4 | 67 | fatty acid beta-oxidation |
| GO:0034109 | 0.01949 | 4.11616 | 1 | 4 | 67 | homotypic cell-cell adhesion |
| GO:0061045 | 0.01949 | 4.11616 | 1 | 4 | 67 | negative regulation of wound healing |
| GO:0019933 | 0.01962 | 2.67977 | 3 | 7 | 177 | cAMP-mediated signaling |
| GO:1901654 | 0.01962 | 2.67977 | 3 | 7 | 177 | response to ketone |
| GO:0051651 | 0.01967 | 3.38126 | 2 | 5 | 101 | maintenance of location in cell |
| GO:0060840 | 0.01967 | 3.38126 | 2 | 5 | 101 | artery development |
| GO:0048706 | 0.01975 | 2.95468 | 2 | 6 | 138 | embryonic skeletal system development |
| GO:0007178 | 0.01976 | 2.12034 | 5 | 11 | 350 | transmembrane receptor protein serine/threonine kinase signaling pathway |
| GO:0045927 | 0.01978 | 2.21299 | 5 | 10 | 305 | positive regulation of growth |
| GO:0034654 | 0.01983 | 1.35504 | 50 | 64 | 3250 | nucleobase-containing compound biosynthetic process |
| GO:0046578 | 0.02006 | 2.47012 | 3 | 8 | 219 | regulation of Ras protein signal transduction |
| GO:0046885 | 0.02024 | 5.54788 | 1 | 3 | 38 | regulation of hormone biosynthetic process |
| GO:0099590 | 0.02024 | 5.54788 | 1 | 3 | 38 | neurotransmitter receptor internalization |
| GO:0048608 | 0.02046 | 1.96970 | 7 | 13 | 445 | reproductive structure development |
| GO:0043407 | 0.02047 | 4.05167 | 1 | 4 | 68 | negative regulation of MAP kinase activity |
| GO:0031667 | 0.02051 | 2.10771 | 5 | 11 | 352 | response to nutrient levels |
| GO:1901566 | 0.02054 | 1.49987 | 24 | 34 | 1539 | organonitrogen compound biosynthetic process |
| GO:0061138 | 0.02055 | 2.45836 | 3 | 8 | 220 | morphogenesis of a branching epithelium |
| GO:0072659 | 0.02064 | 2.31071 | 4 | 9 | 263 | protein localization to plasma membrane |
| GO:0033043 | 0.02087 | 1.56171 | 19 | 28 | 1214 | regulation of organelle organization |
| GO:0045667 | 0.02103 | 2.91032 | 2 | 6 | 140 | regulation of osteoblast differentiation |
| GO:0010632 | 0.02105 | 2.44671 | 3 | 8 | 221 | regulation of epithelial cell migration |
| GO:0010038 | 0.02109 | 2.30154 | 4 | 9 | 264 | response to metal ion |
| GO:0014897 | 0.02121 | 3.31197 | 2 | 5 | 103 | striated muscle hypertrophy |
| GO:0061326 | 0.02121 | 3.31197 | 2 | 5 | 103 | renal tubule development |
| GO:0001541 | 0.02147 | 3.98916 | 1 | 4 | 69 | ovarian follicle development |
| GO:2000107 | 0.02147 | 3.98916 | 1 | 4 | 69 | negative regulation of leukocyte apoptotic process |
| GO:0002739 | 0.02154 | 9.93916 | 0 | 2 | 15 | regulation of cytokine secretion involved in immune response |
| GO:0007379 | 0.02154 | 9.93916 | 0 | 2 | 15 | segment specification |
| GO:0014067 | 0.02154 | 9.93916 | 0 | 2 | 15 | negative regulation of phosphatidylinositol 3-kinase signaling |
| GO:0031268 | 0.02154 | 9.93916 | 0 | 2 | 15 | pseudopodium organization |
| GO:0044241 | 0.02154 | 9.93916 | 0 | 2 | 15 | lipid digestion |
| GO:0048715 | 0.02154 | 9.93916 | 0 | 2 | 15 | negative regulation of oligodendrocyte differentiation |
| GO:0071731 | 0.02154 | 9.93916 | 0 | 2 | 15 | response to nitric oxide |
| GO:0072074 | 0.02154 | 9.93916 | 0 | 2 | 15 | kidney mesenchyme development |
| GO:0072109 | 0.02154 | 9.93916 | 0 | 2 | 15 | glomerular mesangium development |
| GO:0072189 | 0.02154 | 9.93916 | 0 | 2 | 15 | ureter development |
| GO:0098974 | 0.02154 | 9.93916 | 0 | 2 | 15 | postsynaptic actin cytoskeleton organization |
| GO:0099188 | 0.02154 | 9.93916 | 0 | 2 | 15 | postsynaptic cytoskeleton organization |
| GO:0019438 | 0.02166 | 1.34500 | 51 | 65 | 3324 | aromatic compound biosynthetic process |
| GO:0010634 | 0.02169 | 2.88863 | 2 | 6 | 141 | positive regulation of epithelial cell migration |
| GO:0061458 | 0.02182 | 1.95129 | 7 | 13 | 449 | reproductive system development |
| GO:0022408 | 0.02186 | 2.61771 | 3 | 7 | 181 | negative regulation of cell-cell adhesion |
| GO:0032414 | 0.02201 | 3.27837 | 2 | 5 | 104 | positive regulation of ion transmembrane transporter activity |
| GO:0009150 | 0.02228 | 2.00666 | 6 | 12 | 403 | purine ribonucleotide metabolic process |
| GO:0034614 | 0.02237 | 2.86727 | 2 | 6 | 142 | cellular response to reactive oxygen species |
| GO:0046330 | 0.02237 | 2.86727 | 2 | 6 | 142 | positive regulation of JNK cascade |
| GO:1902904 | 0.02237 | 2.86727 | 2 | 6 | 142 | negative regulation of supramolecular fiber organization |
| GO:1990868 | 0.02251 | 3.92855 | 1 | 4 | 70 | response to chemokine |
| GO:1990869 | 0.02251 | 3.92855 | 1 | 4 | 70 | cellular response to chemokine |
| GO:0048812 | 0.02252 | 1.77132 | 10 | 17 | 647 | neuron projection morphogenesis |
| GO:0009056 | 0.02281 | 1.41344 | 33 | 45 | 2170 | catabolic process |
| GO:0030048 | 0.02283 | 3.24544 | 2 | 5 | 105 | actin filament-based movement |
| GO:0045185 | 0.02283 | 3.24544 | 2 | 5 | 105 | maintenance of protein location |
| GO:0070838 | 0.02289 | 1.93769 | 7 | 13 | 452 | divalent metal ion transport |
| GO:0042180 | 0.02305 | 2.58773 | 3 | 7 | 183 | cellular ketone metabolic process |
| GO:0048754 | 0.02305 | 2.58773 | 3 | 7 | 183 | branching morphogenesis of an epithelial tube |
| GO:0010559 | 0.02319 | 5.24753 | 1 | 3 | 40 | regulation of glycoprotein biosynthetic process |
| GO:0034105 | 0.02319 | 5.24753 | 1 | 3 | 40 | positive regulation of tissue remodeling |
| GO:0010822 | 0.02357 | 3.86974 | 1 | 4 | 71 | positive regulation of mitochondrion organization |
| GO:0072171 | 0.02357 | 3.86974 | 1 | 4 | 71 | mesonephric tubule morphogenesis |
| GO:0030183 | 0.02376 | 2.82547 | 2 | 6 | 144 | B cell differentiation |
| GO:0045893 | 0.02391 | 1.48932 | 23 | 33 | 1502 | positive regulation of transcription, DNA-templated |
| GO:0051258 | 0.02395 | 2.24804 | 4 | 9 | 270 | protein polymerization |
| GO:0072511 | 0.02399 | 1.92428 | 7 | 13 | 455 | divalent inorganic cation transport |
| GO:0003414 | 0.02437 | 9.22881 | 0 | 2 | 16 | chondrocyte morphogenesis involved in endochondral bone morphogenesis |
| GO:0003429 | 0.02437 | 9.22881 | 0 | 2 | 16 | growth plate cartilage chondrocyte morphogenesis |
| GO:0010752 | 0.02437 | 9.22881 | 0 | 2 | 16 | regulation of cGMP-mediated signaling |
| GO:0032957 | 0.02437 | 9.22881 | 0 | 2 | 16 | inositol trisphosphate metabolic process |
| GO:0060979 | 0.02437 | 9.22881 | 0 | 2 | 16 | vasculogenesis involved in coronary vascular morphogenesis |
| GO:0072010 | 0.02437 | 9.22881 | 0 | 2 | 16 | glomerular epithelium development |
| GO:0090171 | 0.02437 | 9.22881 | 0 | 2 | 16 | chondrocyte morphogenesis |
| GO:1900452 | 0.02437 | 9.22881 | 0 | 2 | 16 | regulation of long-term synaptic depression |
| GO:1903508 | 0.02451 | 1.48607 | 23 | 33 | 1505 | positive regulation of nucleic acid-templated transcription |
| GO:0071901 | 0.02453 | 3.18153 | 2 | 5 | 107 | negative regulation of protein serine/threonine kinase activity |
| GO:0045935 | 0.02458 | 1.44662 | 27 | 38 | 1784 | positive regulation of nucleobase-containing compound metabolic process |
| GO:1902680 | 0.02472 | 1.48500 | 23 | 33 | 1506 | positive regulation of RNA biosynthetic process |
| GO:0007431 | 0.02474 | 5.10921 | 1 | 3 | 41 | salivary gland development |
| GO:0010470 | 0.02474 | 5.10921 | 1 | 3 | 41 | regulation of gastrulation |
| GO:0032459 | 0.02474 | 5.10921 | 1 | 3 | 41 | regulation of protein oligomerization |
| GO:0051339 | 0.02474 | 5.10921 | 1 | 3 | 41 | regulation of lyase activity |
| GO:1901381 | 0.02474 | 5.10921 | 1 | 3 | 41 | positive regulation of potassium ion transmembrane transport |
| GO:0001894 | 0.02479 | 2.36813 | 3 | 8 | 228 | tissue homeostasis |
| GO:0090092 | 0.02479 | 2.36813 | 3 | 8 | 228 | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
| GO:0060070 | 0.02496 | 2.23074 | 4 | 9 | 272 | canonical Wnt signaling pathway |
| GO:0046034 | 0.02536 | 2.35731 | 4 | 8 | 229 | ATP metabolic process |
| GO:0001776 | 0.02541 | 3.15050 | 2 | 5 | 108 | leukocyte homeostasis |
| GO:0030516 | 0.02541 | 3.15050 | 2 | 5 | 108 | regulation of axon extension |
| GO:0016311 | 0.02544 | 2.03498 | 6 | 11 | 364 | dephosphorylation |
| GO:0016051 | 0.02555 | 2.52978 | 3 | 7 | 187 | carbohydrate biosynthetic process |
| GO:0048771 | 0.02555 | 2.52978 | 3 | 7 | 187 | tissue remodeling |
| GO:0006720 | 0.02579 | 3.75725 | 1 | 4 | 73 | isoprenoid metabolic process |
| GO:0019319 | 0.02579 | 3.75725 | 1 | 4 | 73 | hexose biosynthetic process |
| GO:0021885 | 0.02579 | 3.75725 | 1 | 4 | 73 | forebrain cell migration |
| GO:0051145 | 0.02579 | 3.75725 | 1 | 4 | 73 | smooth muscle cell differentiation |
| GO:0032102 | 0.02595 | 2.11142 | 5 | 10 | 319 | negative regulation of response to external stimulus |
| GO:0046660 | 0.02596 | 2.76498 | 2 | 6 | 147 | female sex differentiation |
| GO:0009259 | 0.02628 | 1.95575 | 6 | 12 | 413 | ribonucleotide metabolic process |
| GO:0006024 | 0.02635 | 4.97799 | 1 | 3 | 42 | glycosaminoglycan biosynthetic process |
| GO:0042181 | 0.02635 | 4.97799 | 1 | 3 | 42 | ketone biosynthetic process |
| GO:0090257 | 0.02652 | 2.33596 | 4 | 8 | 231 | regulation of muscle system process |
| GO:0044262 | 0.02654 | 2.20529 | 4 | 9 | 275 | cellular carbohydrate metabolic process |
| GO:0006937 | 0.02672 | 2.74539 | 2 | 6 | 148 | regulation of muscle contraction |
| GO:0120039 | 0.02692 | 1.73172 | 10 | 17 | 661 | plasma membrane bounded cell projection morphogenesis |
| GO:0050432 | 0.02695 | 3.70341 | 1 | 4 | 74 | catecholamine secretion |
| GO:0051881 | 0.02695 | 3.70341 | 1 | 4 | 74 | regulation of mitochondrial membrane potential |
| GO:0060419 | 0.02723 | 3.09022 | 2 | 5 | 110 | heart growth |
| GO:0003422 | 0.02735 | 8.61318 | 0 | 2 | 17 | growth plate cartilage morphogenesis |
| GO:0006700 | 0.02735 | 8.61318 | 0 | 2 | 17 | C21-steroid hormone biosynthetic process |
| GO:0010919 | 0.02735 | 8.61318 | 0 | 2 | 17 | regulation of inositol phosphate biosynthetic process |
| GO:0032780 | 0.02735 | 8.61318 | 0 | 2 | 17 | negative regulation of ATPase activity |
| GO:0045793 | 0.02735 | 8.61318 | 0 | 2 | 17 | positive regulation of cell size |
| GO:0048739 | 0.02735 | 8.61318 | 0 | 2 | 17 | cardiac muscle fiber development |
| GO:0051350 | 0.02735 | 8.61318 | 0 | 2 | 17 | negative regulation of lyase activity |
| GO:0060973 | 0.02735 | 8.61318 | 0 | 2 | 17 | cell migration involved in heart development |
| GO:0072234 | 0.02735 | 8.61318 | 0 | 2 | 17 | metanephric nephron tubule development |
| GO:1903960 | 0.02735 | 8.61318 | 0 | 2 | 17 | negative regulation of anion transmembrane transport |
| GO:0015718 | 0.02750 | 2.72607 | 2 | 6 | 149 | monocarboxylic acid transport |
| GO:1903169 | 0.02750 | 2.72607 | 2 | 6 | 149 | regulation of calcium ion transmembrane transport |
| GO:0006006 | 0.02754 | 2.48798 | 3 | 7 | 190 | glucose metabolic process |
| GO:0006469 | 0.02754 | 2.48798 | 3 | 7 | 190 | negative regulation of protein kinase activity |
| GO:0048858 | 0.02794 | 1.72346 | 10 | 17 | 664 | cell projection morphogenesis |
| GO:0001569 | 0.02801 | 4.85333 | 1 | 3 | 43 | branching involved in blood vessel morphogenesis |
| GO:0030166 | 0.02801 | 4.85333 | 1 | 3 | 43 | proteoglycan biosynthetic process |
| GO:0032371 | 0.02801 | 4.85333 | 1 | 3 | 43 | regulation of sterol transport |
| GO:0032374 | 0.02801 | 4.85333 | 1 | 3 | 43 | regulation of cholesterol transport |
| GO:0032507 | 0.02813 | 3.65109 | 1 | 4 | 75 | maintenance of protein location in cell |
| GO:0070613 | 0.02813 | 3.65109 | 1 | 4 | 75 | regulation of protein processing |
| GO:1901606 | 0.02813 | 3.65109 | 1 | 4 | 75 | alpha-amino acid catabolic process |
| GO:0032411 | 0.02817 | 3.06093 | 2 | 5 | 111 | positive regulation of transporter activity |
| GO:0051282 | 0.02817 | 3.06093 | 2 | 5 | 111 | regulation of sequestering of calcium ion |
| GO:0071804 | 0.02823 | 2.47435 | 3 | 7 | 191 | cellular potassium ion transport |
| GO:0071805 | 0.02823 | 2.47435 | 3 | 7 | 191 | potassium ion transmembrane transport |
| GO:0080134 | 0.02825 | 1.51712 | 19 | 28 | 1247 | regulation of response to stress |
| GO:0051494 | 0.02829 | 2.70702 | 2 | 6 | 150 | negative regulation of cytoskeleton organization |
| GO:0016055 | 0.02847 | 1.93123 | 6 | 12 | 418 | Wnt signaling pathway |
| GO:0006996 | 0.02856 | 1.31709 | 53 | 67 | 3492 | organelle organization |
| GO:0031032 | 0.02893 | 2.46087 | 3 | 7 | 192 | actomyosin structure organization |
| GO:0050866 | 0.02893 | 2.46087 | 3 | 7 | 192 | negative regulation of cell activation |
| GO:2000377 | 0.02893 | 2.46087 | 3 | 7 | 192 | regulation of reactive oxygen species metabolic process |
| GO:0051208 | 0.02913 | 3.03219 | 2 | 5 | 112 | sequestering of calcium ion |
| GO:0072521 | 0.02923 | 1.86822 | 7 | 13 | 468 | purine-containing compound metabolic process |
| GO:0044272 | 0.02935 | 3.60022 | 1 | 4 | 76 | sulfur compound biosynthetic process |
| GO:0055008 | 0.02935 | 3.60022 | 1 | 4 | 76 | cardiac muscle tissue morphogenesis |
| GO:1901862 | 0.02935 | 3.60022 | 1 | 4 | 76 | negative regulation of muscle tissue development |
| GO:0198738 | 0.02938 | 1.92160 | 6 | 12 | 420 | cell-cell signaling by wnt |
| GO:0002063 | 0.02973 | 4.73475 | 1 | 3 | 44 | chondrocyte development |
| GO:0032873 | 0.02973 | 4.73475 | 1 | 3 | 44 | negative regulation of stress-activated MAPK cascade |
| GO:0070303 | 0.02973 | 4.73475 | 1 | 3 | 44 | negative regulation of stress-activated protein kinase signaling cascade |
| GO:0006875 | 0.02974 | 1.77624 | 9 | 15 | 568 | cellular metal ion homeostasis |
| GO:0000302 | 0.03036 | 2.43433 | 3 | 7 | 194 | response to reactive oxygen species |
| GO:0006060 | 0.03040 | 64.45634 | 0 | 1 | 2 | sorbitol metabolic process |
| GO:0006550 | 0.03040 | 64.45634 | 0 | 1 | 2 | isoleucine catabolic process |
| GO:0007231 | 0.03040 | 64.45634 | 0 | 1 | 2 | osmosensory signaling pathway |
| GO:0009082 | 0.03040 | 64.45634 | 0 | 1 | 2 | branched-chain amino acid biosynthetic process |
| GO:0009098 | 0.03040 | 64.45634 | 0 | 1 | 2 | leucine biosynthetic process |
| GO:0009099 | 0.03040 | 64.45634 | 0 | 1 | 2 | valine biosynthetic process |
| GO:0010747 | 0.03040 | 64.45634 | 0 | 1 | 2 | positive regulation of plasma membrane long-chain fatty acid transport |
| GO:0010903 | 0.03040 | 64.45634 | 0 | 1 | 2 | negative regulation of very-low-density lipoprotein particle remodeling |
| GO:0010920 | 0.03040 | 64.45634 | 0 | 1 | 2 | negative regulation of inositol phosphate biosynthetic process |
| GO:0014805 | 0.03040 | 64.45634 | 0 | 1 | 2 | smooth muscle adaptation |
| GO:0014852 | 0.03040 | 64.45634 | 0 | 1 | 2 | regulation of skeletal muscle contraction by neural stimulation via neuromuscular junction |
| GO:0014853 | 0.03040 | 64.45634 | 0 | 1 | 2 | regulation of excitatory postsynaptic membrane potential involved in skeletal muscle contraction |
| GO:0015688 | 0.03040 | 64.45634 | 0 | 1 | 2 | iron chelate transport |
| GO:0015891 | 0.03040 | 64.45634 | 0 | 1 | 2 | siderophore transport |
| GO:0019417 | 0.03040 | 64.45634 | 0 | 1 | 2 | sulfur oxidation |
| GO:0021560 | 0.03040 | 64.45634 | 0 | 1 | 2 | abducens nerve development |
| GO:0021598 | 0.03040 | 64.45634 | 0 | 1 | 2 | abducens nerve morphogenesis |
| GO:0021599 | 0.03040 | 64.45634 | 0 | 1 | 2 | abducens nerve formation |
| GO:0021649 | 0.03040 | 64.45634 | 0 | 1 | 2 | vestibulocochlear nerve structural organization |
| GO:0030185 | 0.03040 | 64.45634 | 0 | 1 | 2 | nitric oxide transport |
| GO:0032487 | 0.03040 | 64.45634 | 0 | 1 | 2 | regulation of Rap protein signal transduction |
| GO:0033364 | 0.03040 | 64.45634 | 0 | 1 | 2 | mast cell secretory granule organization |
| GO:0034117 | 0.03040 | 64.45634 | 0 | 1 | 2 | erythrocyte aggregation |
| GO:0034118 | 0.03040 | 64.45634 | 0 | 1 | 2 | regulation of erythrocyte aggregation |
| GO:0034699 | 0.03040 | 64.45634 | 0 | 1 | 2 | response to luteinizing hormone |
| GO:0035026 | 0.03040 | 64.45634 | 0 | 1 | 2 | leading edge cell differentiation |
| GO:0035377 | 0.03040 | 64.45634 | 0 | 1 | 2 | transepithelial water transport |
| GO:0035691 | 0.03040 | 64.45634 | 0 | 1 | 2 | macrophage migration inhibitory factor signaling pathway |
| GO:0038116 | 0.03040 | 64.45634 | 0 | 1 | 2 | chemokine (C-C motif) ligand 21 signaling pathway |
| GO:0038195 | 0.03040 | 64.45634 | 0 | 1 | 2 | urokinase plasminogen activator signaling pathway |
| GO:0046370 | 0.03040 | 64.45634 | 0 | 1 | 2 | fructose biosynthetic process |
| GO:0060197 | 0.03040 | 64.45634 | 0 | 1 | 2 | cloacal septation |
| GO:0060327 | 0.03040 | 64.45634 | 0 | 1 | 2 | cytoplasmic actin-based contraction involved in cell motility |
| GO:0060354 | 0.03040 | 64.45634 | 0 | 1 | 2 | negative regulation of cell adhesion molecule production |
| GO:0060721 | 0.03040 | 64.45634 | 0 | 1 | 2 | regulation of spongiotrophoblast cell proliferation |
| GO:0060723 | 0.03040 | 64.45634 | 0 | 1 | 2 | regulation of cell proliferation involved in embryonic placenta development |
| GO:0060857 | 0.03040 | 64.45634 | 0 | 1 | 2 | establishment of glial blood-brain barrier |
| GO:0060935 | 0.03040 | 64.45634 | 0 | 1 | 2 | cardiac fibroblast cell differentiation |
| GO:0060936 | 0.03040 | 64.45634 | 0 | 1 | 2 | cardiac fibroblast cell development |
| GO:0060938 | 0.03040 | 64.45634 | 0 | 1 | 2 | epicardium-derived cardiac fibroblast cell differentiation |
| GO:0060939 | 0.03040 | 64.45634 | 0 | 1 | 2 | epicardium-derived cardiac fibroblast cell development |
| GO:0060994 | 0.03040 | 64.45634 | 0 | 1 | 2 | regulation of transcription from RNA polymerase II promoter involved in kidney development |
| GO:0061552 | 0.03040 | 64.45634 | 0 | 1 | 2 | ganglion morphogenesis |
| GO:0070650 | 0.03040 | 64.45634 | 0 | 1 | 2 | actin filament bundle distribution |
| GO:0070839 | 0.03040 | 64.45634 | 0 | 1 | 2 | divalent metal ion export |
| GO:0071812 | 0.03040 | 64.45634 | 0 | 1 | 2 | positive regulation of fever generation by positive regulation of prostaglandin secretion |
| GO:0071848 | 0.03040 | 64.45634 | 0 | 1 | 2 | positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling |
| GO:0072071 | 0.03040 | 64.45634 | 0 | 1 | 2 | kidney interstitial fibroblast differentiation |
| GO:0072141 | 0.03040 | 64.45634 | 0 | 1 | 2 | renal interstitial fibroblast development |
| GO:0072166 | 0.03040 | 64.45634 | 0 | 1 | 2 | posterior mesonephric tubule development |
| GO:0072185 | 0.03040 | 64.45634 | 0 | 1 | 2 | metanephric cap development |
| GO:0072186 | 0.03040 | 64.45634 | 0 | 1 | 2 | metanephric cap morphogenesis |
| GO:0072278 | 0.03040 | 64.45634 | 0 | 1 | 2 | metanephric comma-shaped body morphogenesis |
| GO:0090094 | 0.03040 | 64.45634 | 0 | 1 | 2 | metanephric cap mesenchymal cell proliferation involved in metanephros development |
| GO:0097274 | 0.03040 | 64.45634 | 0 | 1 | 2 | urea homeostasis |
| GO:0098886 | 0.03040 | 64.45634 | 0 | 1 | 2 | modification of dendritic spine |
| GO:1902460 | 0.03040 | 64.45634 | 0 | 1 | 2 | regulation of mesenchymal stem cell proliferation |
| GO:1902462 | 0.03040 | 64.45634 | 0 | 1 | 2 | positive regulation of mesenchymal stem cell proliferation |
| GO:1902954 | 0.03040 | 64.45634 | 0 | 1 | 2 | regulation of early endosome to recycling endosome transport |
| GO:1902960 | 0.03040 | 64.45634 | 0 | 1 | 2 | negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process |
| GO:1902962 | 0.03040 | 64.45634 | 0 | 1 | 2 | regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process |
| GO:1902963 | 0.03040 | 64.45634 | 0 | 1 | 2 | negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process |
| GO:1902988 | 0.03040 | 64.45634 | 0 | 1 | 2 | neurofibrillary tangle assembly |
| GO:1902996 | 0.03040 | 64.45634 | 0 | 1 | 2 | regulation of neurofibrillary tangle assembly |
| GO:1903874 | 0.03040 | 64.45634 | 0 | 1 | 2 | ferrous iron transmembrane transport |
| GO:1904049 | 0.03040 | 64.45634 | 0 | 1 | 2 | negative regulation of spontaneous neurotransmitter secretion |
| GO:1904204 | 0.03040 | 64.45634 | 0 | 1 | 2 | regulation of skeletal muscle hypertrophy |
| GO:1904612 | 0.03040 | 64.45634 | 0 | 1 | 2 | response to 2,3,7,8-tetrachlorodibenzodioxine |
| GO:1904613 | 0.03040 | 64.45634 | 0 | 1 | 2 | cellular response to 2,3,7,8-tetrachlorodibenzodioxine |
| GO:1904835 | 0.03040 | 64.45634 | 0 | 1 | 2 | dorsal root ganglion morphogenesis |
| GO:1905123 | 0.03040 | 64.45634 | 0 | 1 | 2 | regulation of glucosylceramidase activity |
| GO:1905246 | 0.03040 | 64.45634 | 0 | 1 | 2 | negative regulation of aspartic-type peptidase activity |
| GO:1905407 | 0.03040 | 64.45634 | 0 | 1 | 2 | regulation of creatine transmembrane transporter activity |
| GO:1905408 | 0.03040 | 64.45634 | 0 | 1 | 2 | negative regulation of creatine transmembrane transporter activity |
| GO:1905636 | 0.03040 | 64.45634 | 0 | 1 | 2 | positive regulation of RNA polymerase II regulatory region sequence-specific DNA binding |
| GO:1990079 | 0.03040 | 64.45634 | 0 | 1 | 2 | cartilage homeostasis |
| GO:1990408 | 0.03040 | 64.45634 | 0 | 1 | 2 | calcitonin gene-related peptide receptor signaling pathway |
| GO:2000866 | 0.03040 | 64.45634 | 0 | 1 | 2 | positive regulation of estradiol secretion |
| GO:0010544 | 0.03046 | 8.07451 | 0 | 2 | 18 | negative regulation of platelet activation |
| GO:0030502 | 0.03046 | 8.07451 | 0 | 2 | 18 | negative regulation of bone mineralization |
| GO:0030540 | 0.03046 | 8.07451 | 0 | 2 | 18 | female genitalia development |
| GO:0034111 | 0.03046 | 8.07451 | 0 | 2 | 18 | negative regulation of homotypic cell-cell adhesion |
| GO:0046184 | 0.03046 | 8.07451 | 0 | 2 | 18 | aldehyde biosynthetic process |
| GO:0050860 | 0.03046 | 8.07451 | 0 | 2 | 18 | negative regulation of T cell receptor signaling pathway |
| GO:0060628 | 0.03046 | 8.07451 | 0 | 2 | 18 | regulation of ER to Golgi vesicle-mediated transport |
| GO:0060841 | 0.03046 | 8.07451 | 0 | 2 | 18 | venous blood vessel development |
| GO:0090030 | 0.03046 | 8.07451 | 0 | 2 | 18 | regulation of steroid hormone biosynthetic process |
| GO:0090185 | 0.03046 | 8.07451 | 0 | 2 | 18 | negative regulation of kidney development |
| GO:1904424 | 0.03046 | 8.07451 | 0 | 2 | 18 | regulation of GTP binding |
| GO:2000846 | 0.03046 | 8.07451 | 0 | 2 | 18 | regulation of corticosteroid hormone secretion |
| GO:0060562 | 0.03066 | 1.97252 | 6 | 11 | 375 | epithelial tube morphogenesis |
| GO:0031326 | 0.03066 | 1.31572 | 52 | 65 | 3386 | regulation of cellular biosynthetic process |
| GO:0051222 | 0.03078 | 1.90732 | 6 | 12 | 423 | positive regulation of protein transport |
| GO:0006470 | 0.03089 | 2.26417 | 4 | 8 | 238 | protein dephosphorylation |
| GO:0030111 | 0.03108 | 2.14015 | 4 | 9 | 283 | regulation of Wnt signaling pathway |
| GO:0043534 | 0.03112 | 2.97629 | 2 | 5 | 114 | blood vessel endothelial cell migration |
| GO:0090407 | 0.03145 | 1.84750 | 7 | 13 | 473 | organophosphate biosynthetic process |
| GO:0070169 | 0.03150 | 4.62181 | 1 | 3 | 45 | positive regulation of biomineral tissue development |
| GO:0071470 | 0.03150 | 4.62181 | 1 | 3 | 45 | cellular response to osmotic stress |
| GO:1903018 | 0.03150 | 4.62181 | 1 | 3 | 45 | regulation of glycoprotein metabolic process |
| GO:0001763 | 0.03156 | 2.25427 | 4 | 8 | 239 | morphogenesis of a branching structure |
| GO:0031334 | 0.03156 | 2.25427 | 4 | 8 | 239 | positive regulation of protein complex assembly |
| GO:0032269 | 0.03165 | 1.56707 | 15 | 23 | 989 | negative regulation of cellular protein metabolic process |
| GO:0019221 | 0.03169 | 2.03784 | 5 | 10 | 330 | cytokine-mediated signaling pathway |
| GO:0002312 | 0.03187 | 3.50261 | 1 | 4 | 78 | B cell activation involved in immune response |
| GO:0043507 | 0.03187 | 3.50261 | 1 | 4 | 78 | positive regulation of JUN kinase activity |
| GO:0050805 | 0.03187 | 3.50261 | 1 | 4 | 78 | negative regulation of synaptic transmission |
| GO:0071674 | 0.03187 | 3.50261 | 1 | 4 | 78 | mononuclear cell migration |
| GO:0098657 | 0.03200 | 1.61999 | 13 | 20 | 831 | import into cell |
| GO:0030003 | 0.03235 | 1.72116 | 10 | 16 | 625 | cellular cation homeostasis |
| GO:0042391 | 0.03273 | 1.88860 | 7 | 12 | 427 | regulation of membrane potential |
| GO:0008202 | 0.03291 | 2.11669 | 4 | 9 | 286 | steroid metabolic process |
| GO:0090277 | 0.03318 | 2.92241 | 2 | 5 | 116 | positive regulation of peptide hormone secretion |
| GO:0003208 | 0.03318 | 3.45576 | 1 | 4 | 79 | cardiac ventricle morphogenesis |
| GO:0015748 | 0.03318 | 3.45576 | 1 | 4 | 79 | organophosphate ester transport |
| GO:0046364 | 0.03318 | 3.45576 | 1 | 4 | 79 | monosaccharide biosynthetic process |
| GO:0072078 | 0.03318 | 3.45576 | 1 | 4 | 79 | nephron tubule morphogenesis |
| GO:0051254 | 0.03322 | 1.43832 | 24 | 34 | 1599 | positive regulation of RNA metabolic process |
| GO:0006163 | 0.03323 | 1.88397 | 7 | 12 | 428 | purine nucleotide metabolic process |
| GO:0071385 | 0.03333 | 4.51413 | 1 | 3 | 46 | cellular response to glucocorticoid stimulus |
| GO:0007160 | 0.03337 | 2.38293 | 3 | 7 | 198 | cell-matrix adhesion |
| GO:0071214 | 0.03354 | 2.10898 | 4 | 9 | 287 | cellular response to abiotic stimulus |
| GO:0104004 | 0.03354 | 2.10898 | 4 | 9 | 287 | cellular response to environmental stimulus |
| GO:0001818 | 0.03360 | 2.22507 | 4 | 8 | 242 | negative regulation of cytokine production |
| GO:0006027 | 0.03370 | 7.59920 | 0 | 2 | 19 | glycosaminoglycan catabolic process |
| GO:0006089 | 0.03370 | 7.59920 | 0 | 2 | 19 | lactate metabolic process |
| GO:0006907 | 0.03370 | 7.59920 | 0 | 2 | 19 | pinocytosis |
| GO:0010766 | 0.03370 | 7.59920 | 0 | 2 | 19 | negative regulation of sodium ion transport |
| GO:0032823 | 0.03370 | 7.59920 | 0 | 2 | 19 | regulation of natural killer cell differentiation |
| GO:0035930 | 0.03370 | 7.59920 | 0 | 2 | 19 | corticosteroid hormone secretion |
| GO:0046827 | 0.03370 | 7.59920 | 0 | 2 | 19 | positive regulation of protein export from nucleus |
| GO:0050884 | 0.03370 | 7.59920 | 0 | 2 | 19 | neuromuscular process controlling posture |
| GO:0051956 | 0.03370 | 7.59920 | 0 | 2 | 19 | negative regulation of amino acid transport |
| GO:0060456 | 0.03370 | 7.59920 | 0 | 2 | 19 | positive regulation of digestive system process |
| GO:0070208 | 0.03370 | 7.59920 | 0 | 2 | 19 | protein heterotrimerization |
| GO:1903798 | 0.03370 | 7.59920 | 0 | 2 | 19 | regulation of production of miRNAs involved in gene silencing by miRNA |
| GO:0006357 | 0.03374 | 1.39713 | 30 | 40 | 1941 | regulation of transcription by RNA polymerase II |
| GO:0043009 | 0.03394 | 1.63008 | 12 | 19 | 784 | chordate embryonic development |
| GO:0048598 | 0.03399 | 1.70962 | 10 | 16 | 629 | embryonic morphogenesis |
| GO:0099175 | 0.03425 | 2.89619 | 2 | 5 | 117 | regulation of postsynapse organization |
| GO:0071356 | 0.03425 | 2.58074 | 2 | 6 | 157 | cellular response to tumor necrosis factor |
| GO:0019693 | 0.03425 | 1.87479 | 7 | 12 | 430 | ribose phosphate metabolic process |
| GO:0055082 | 0.03431 | 1.62788 | 12 | 19 | 785 | cellular chemical homeostasis |
| GO:0006366 | 0.03439 | 1.38944 | 31 | 41 | 2001 | transcription by RNA polymerase II |
| GO:0006970 | 0.03452 | 3.41014 | 1 | 4 | 80 | response to osmotic stress |
| GO:0010468 | 0.03459 | 1.29285 | 58 | 71 | 3768 | regulation of gene expression |
| GO:0042110 | 0.03476 | 1.81924 | 7 | 13 | 480 | T cell activation |
| GO:0042886 | 0.03489 | 1.41114 | 27 | 37 | 1775 | amide transport |
| GO:2001020 | 0.03495 | 2.35803 | 3 | 7 | 200 | regulation of response to DNA damage stimulus |
| GO:0003179 | 0.03521 | 4.41134 | 1 | 3 | 47 | heart valve morphogenesis |
| GO:0032892 | 0.03521 | 4.41134 | 1 | 3 | 47 | positive regulation of organic acid transport |
| GO:0051489 | 0.03521 | 4.41134 | 1 | 3 | 47 | regulation of filopodium assembly |
| GO:0061001 | 0.03521 | 4.41134 | 1 | 3 | 47 | regulation of dendritic spine morphogenesis |
| GO:0001889 | 0.03533 | 2.87043 | 2 | 5 | 118 | liver development |
| GO:0051952 | 0.03533 | 2.87043 | 2 | 5 | 118 | regulation of amine transport |
| GO:0010975 | 0.03566 | 1.73129 | 9 | 15 | 582 | regulation of neuron projection development |
| GO:0072088 | 0.03589 | 3.36570 | 1 | 4 | 81 | nephron epithelium morphogenesis |
| GO:0050954 | 0.03614 | 2.07870 | 4 | 9 | 291 | sensory perception of mechanical stimulus |
| GO:0032990 | 0.03634 | 1.66514 | 11 | 17 | 686 | cell part morphogenesis |
| GO:0032103 | 0.03681 | 2.07126 | 4 | 9 | 292 | positive regulation of response to external stimulus |
| GO:0060284 | 0.03688 | 1.52596 | 16 | 24 | 1059 | regulation of cell development |
| GO:0060401 | 0.03703 | 2.53013 | 2 | 6 | 160 | cytosolic calcium ion transport |
| GO:0002374 | 0.03707 | 7.17671 | 0 | 2 | 20 | cytokine secretion involved in immune response |
| GO:0003094 | 0.03707 | 7.17671 | 0 | 2 | 20 | glomerular filtration |
| GO:0010560 | 0.03707 | 7.17671 | 0 | 2 | 20 | positive regulation of glycoprotein biosynthetic process |
| GO:0033605 | 0.03707 | 7.17671 | 0 | 2 | 20 | positive regulation of catecholamine secretion |
| GO:0061323 | 0.03707 | 7.17671 | 0 | 2 | 20 | cell proliferation involved in heart morphogenesis |
| GO:0070920 | 0.03707 | 7.17671 | 0 | 2 | 20 | regulation of production of small RNA involved in gene silencing by RNA |
| GO:0072087 | 0.03707 | 7.17671 | 0 | 2 | 20 | renal vesicle development |
| GO:0072170 | 0.03707 | 7.17671 | 0 | 2 | 20 | metanephric tubule development |
| GO:0072243 | 0.03707 | 7.17671 | 0 | 2 | 20 | metanephric nephron epithelium development |
| GO:0090330 | 0.03707 | 7.17671 | 0 | 2 | 20 | regulation of platelet aggregation |
| GO:2000136 | 0.03707 | 7.17671 | 0 | 2 | 20 | regulation of cell proliferation involved in heart morphogenesis |
| GO:2000193 | 0.03707 | 7.17671 | 0 | 2 | 20 | positive regulation of fatty acid transport |
| GO:2000353 | 0.03707 | 7.17671 | 0 | 2 | 20 | positive regulation of endothelial cell apoptotic process |
| GO:0030195 | 0.03714 | 4.31313 | 1 | 3 | 48 | negative regulation of blood coagulation |
| GO:0043030 | 0.03714 | 4.31313 | 1 | 3 | 48 | regulation of macrophage activation |
| GO:0061005 | 0.03714 | 4.31313 | 1 | 3 | 48 | cell differentiation involved in kidney development |
| GO:0071384 | 0.03714 | 4.31313 | 1 | 3 | 48 | cellular response to corticosteroid stimulus |
| GO:0071407 | 0.03727 | 1.79957 | 7 | 13 | 485 | cellular response to organic cyclic compound |
| GO:0051899 | 0.03729 | 3.32241 | 1 | 4 | 82 | membrane depolarization |
| GO:0072028 | 0.03729 | 3.32241 | 1 | 4 | 82 | nephron morphogenesis |
| GO:1903035 | 0.03729 | 3.32241 | 1 | 4 | 82 | negative regulation of response to wounding |
| GO:0007188 | 0.03741 | 2.32163 | 3 | 7 | 203 | adenylate cyclase-modulating G protein-coupled receptor signaling pathway |
| GO:0007586 | 0.03756 | 2.82027 | 2 | 5 | 120 | digestion |
| GO:0080135 | 0.03789 | 1.68421 | 10 | 16 | 638 | regulation of cellular response to stress |
| GO:0021537 | 0.03796 | 2.16887 | 4 | 8 | 248 | telencephalon development |
| GO:0006873 | 0.03834 | 1.68143 | 10 | 16 | 639 | cellular ion homeostasis |
| GO:0061008 | 0.03871 | 2.79583 | 2 | 5 | 121 | hepaticobiliary system development |
| GO:0003151 | 0.03873 | 3.28021 | 1 | 4 | 83 | outflow tract morphogenesis |
| GO:0060079 | 0.03873 | 3.28021 | 1 | 4 | 83 | excitatory postsynaptic potential |
| GO:0060326 | 0.03887 | 2.04926 | 5 | 9 | 295 | cell chemotaxis |
| GO:0045124 | 0.03913 | 4.21918 | 1 | 3 | 49 | regulation of bone resorption |
| GO:1900047 | 0.03913 | 4.21918 | 1 | 3 | 49 | negative regulation of hemostasis |
| GO:2001222 | 0.03913 | 4.21918 | 1 | 3 | 49 | regulation of neuron migration |
| GO:0001817 | 0.03926 | 1.67590 | 10 | 16 | 641 | regulation of cytokine production |
| GO:0120031 | 0.03937 | 1.78413 | 7 | 13 | 489 | plasma membrane bounded cell projection assembly |
| GO:0016192 | 0.03938 | 1.43956 | 22 | 31 | 1453 | vesicle-mediated transport |
| GO:0006644 | 0.03956 | 1.95716 | 5 | 10 | 343 | phospholipid metabolic process |
| GO:0015849 | 0.03957 | 2.04203 | 5 | 9 | 296 | organic acid transport |
| GO:0017144 | 0.03981 | 1.64487 | 11 | 17 | 694 | drug metabolic process |
| GO:0002761 | 0.03988 | 2.77181 | 2 | 5 | 122 | regulation of myeloid leukocyte differentiation |
| GO:0015837 | 0.03988 | 2.77181 | 2 | 5 | 122 | amine transport |
| GO:0044271 | 0.04000 | 1.27721 | 60 | 73 | 3918 | cellular nitrogen compound biosynthetic process |
| GO:0120035 | 0.04013 | 1.61838 | 11 | 18 | 747 | regulation of plasma membrane bounded cell projection organization |
| GO:0048638 | 0.04018 | 1.88308 | 6 | 11 | 392 | regulation of developmental growth |
| GO:0051098 | 0.04018 | 1.88308 | 6 | 11 | 392 | regulation of binding |
| GO:0042475 | 0.04019 | 3.23906 | 1 | 4 | 84 | odontogenesis of dentin-containing tooth |
| GO:0070252 | 0.04019 | 3.23906 | 1 | 4 | 84 | actin-mediated cell contraction |
| GO:1904951 | 0.04025 | 1.82583 | 7 | 12 | 441 | positive regulation of establishment of protein localization |
| GO:0003433 | 0.04057 | 6.79869 | 0 | 2 | 21 | chondrocyte development involved in endochondral bone morphogenesis |
| GO:0006691 | 0.04057 | 6.79869 | 0 | 2 | 21 | leukotriene metabolic process |
| GO:0095500 | 0.04057 | 6.79869 | 0 | 2 | 21 | acetylcholine receptor signaling pathway |
| GO:0097205 | 0.04057 | 6.79869 | 0 | 2 | 21 | renal filtration |
| GO:1901017 | 0.04057 | 6.79869 | 0 | 2 | 21 | negative regulation of potassium ion transmembrane transporter activity |
| GO:1903831 | 0.04057 | 6.79869 | 0 | 2 | 21 | signal transduction involved in cellular response to ammonium ion |
| GO:1905144 | 0.04057 | 6.79869 | 0 | 2 | 21 | response to acetylcholine |
| GO:1905145 | 0.04057 | 6.79869 | 0 | 2 | 21 | cellular response to acetylcholine |
| GO:0019725 | 0.04085 | 1.55451 | 14 | 21 | 908 | cellular homeostasis |
| GO:0009152 | 0.04085 | 2.27480 | 3 | 7 | 207 | purine ribonucleotide biosynthetic process |
| GO:0048588 | 0.04107 | 2.13294 | 4 | 8 | 252 | developmental cell growth |
| GO:0032273 | 0.04107 | 2.74820 | 2 | 5 | 123 | positive regulation of protein polymerization |
| GO:0061387 | 0.04107 | 2.74820 | 2 | 5 | 123 | regulation of extent of cell growth |
| GO:0009792 | 0.04110 | 1.59131 | 12 | 19 | 802 | embryo development ending in birth or egg hatching |
| GO:0035924 | 0.04117 | 4.12923 | 1 | 3 | 50 | cellular response to vascular endothelial growth factor stimulus |
| GO:0043268 | 0.04117 | 4.12923 | 1 | 3 | 50 | positive regulation of potassium ion transport |
| GO:0044058 | 0.04117 | 4.12923 | 1 | 3 | 50 | regulation of digestive system process |
| GO:0050819 | 0.04117 | 4.12923 | 1 | 3 | 50 | negative regulation of coagulation |
| GO:0070542 | 0.04117 | 4.12923 | 1 | 3 | 50 | response to fatty acid |
| GO:0098815 | 0.04117 | 4.12923 | 1 | 3 | 50 | modulation of excitatory postsynaptic potential |
| GO:1900024 | 0.04117 | 4.12923 | 1 | 3 | 50 | regulation of substrate adhesion-dependent cell spreading |
| GO:0015908 | 0.04169 | 3.19893 | 1 | 4 | 85 | fatty acid transport |
| GO:0045833 | 0.04169 | 3.19893 | 1 | 4 | 85 | negative regulation of lipid metabolic process |
| GO:0061333 | 0.04169 | 3.19893 | 1 | 4 | 85 | renal tubule morphogenesis |
| GO:0002573 | 0.04265 | 2.25208 | 3 | 7 | 209 | myeloid leukocyte differentiation |
| GO:0009167 | 0.04268 | 2.11541 | 4 | 8 | 254 | purine ribonucleoside monophosphate metabolic process |
| GO:0009205 | 0.04268 | 2.11541 | 4 | 8 | 254 | purine ribonucleoside triphosphate metabolic process |
| GO:1903706 | 0.04269 | 1.86319 | 6 | 11 | 396 | regulation of hemopoiesis |
| GO:0010717 | 0.04321 | 3.15978 | 1 | 4 | 86 | regulation of epithelial to mesenchymal transition |
| GO:0022900 | 0.04321 | 3.15978 | 1 | 4 | 86 | electron transport chain |
| GO:0044344 | 0.04321 | 3.15978 | 1 | 4 | 86 | cellular response to fibroblast growth factor stimulus |
| GO:0051492 | 0.04321 | 3.15978 | 1 | 4 | 86 | regulation of stress fiber assembly |
| GO:0060411 | 0.04321 | 3.15978 | 1 | 4 | 86 | cardiac septum morphogenesis |
| GO:0001662 | 0.04326 | 4.04302 | 1 | 3 | 51 | behavioral fear response |
| GO:0001974 | 0.04326 | 4.04302 | 1 | 3 | 51 | blood vessel remodeling |
| GO:0002209 | 0.04326 | 4.04302 | 1 | 3 | 51 | behavioral defense response |
| GO:0042982 | 0.04326 | 4.04302 | 1 | 3 | 51 | amyloid precursor protein metabolic process |
| GO:0046902 | 0.04326 | 4.04302 | 1 | 3 | 51 | regulation of mitochondrial membrane permeability |
| GO:0060412 | 0.04326 | 4.04302 | 1 | 3 | 51 | ventricular septum morphogenesis |
| GO:0034097 | 0.04329 | 1.52743 | 15 | 22 | 968 | response to cytokine |
| GO:0009126 | 0.04350 | 2.10675 | 4 | 8 | 255 | purine nucleoside monophosphate metabolic process |
| GO:1901343 | 0.04351 | 2.70216 | 2 | 5 | 125 | negative regulation of vasculature development |
| GO:0050920 | 0.04357 | 2.24089 | 3 | 7 | 210 | regulation of chemotaxis |
| GO:0031344 | 0.04418 | 1.59799 | 12 | 18 | 756 | regulation of cell projection organization |
| GO:0002320 | 0.04419 | 6.45847 | 0 | 2 | 22 | lymphoid progenitor cell differentiation |
| GO:0003418 | 0.04419 | 6.45847 | 0 | 2 | 22 | growth plate cartilage chondrocyte differentiation |
| GO:0014912 | 0.04419 | 6.45847 | 0 | 2 | 22 | negative regulation of smooth muscle cell migration |
| GO:0032462 | 0.04419 | 6.45847 | 0 | 2 | 22 | regulation of protein homooligomerization |
| GO:0034694 | 0.04419 | 6.45847 | 0 | 2 | 22 | response to prostaglandin |
| GO:0043567 | 0.04419 | 6.45847 | 0 | 2 | 22 | regulation of insulin-like growth factor receptor signaling pathway |
| GO:0045606 | 0.04419 | 6.45847 | 0 | 2 | 22 | positive regulation of epidermal cell differentiation |
| GO:0046597 | 0.04419 | 6.45847 | 0 | 2 | 22 | negative regulation of viral entry into host cell |
| GO:0060080 | 0.04419 | 6.45847 | 0 | 2 | 22 | inhibitory postsynaptic potential |
| GO:0060390 | 0.04419 | 6.45847 | 0 | 2 | 22 | regulation of SMAD protein signal transduction |
| GO:0072215 | 0.04419 | 6.45847 | 0 | 2 | 22 | regulation of metanephros development |
| GO:1902003 | 0.04419 | 6.45847 | 0 | 2 | 22 | regulation of amyloid-beta formation |
| GO:1902307 | 0.04419 | 6.45847 | 0 | 2 | 22 | positive regulation of sodium ion transmembrane transport |
| GO:1903020 | 0.04419 | 6.45847 | 0 | 2 | 22 | positive regulation of glycoprotein metabolic process |
| GO:0042593 | 0.04434 | 2.09816 | 4 | 8 | 256 | glucose homeostasis |
| GO:0002791 | 0.04441 | 1.75032 | 8 | 13 | 498 | regulation of peptide secretion |
| GO:0048667 | 0.04446 | 1.67667 | 9 | 15 | 600 | cell morphogenesis involved in neuron differentiation |
| GO:0031668 | 0.04450 | 2.22980 | 3 | 7 | 211 | cellular response to extracellular stimulus |
| GO:0001656 | 0.04477 | 3.12158 | 1 | 4 | 87 | metanephros development |
| GO:0002682 | 0.04489 | 1.42951 | 22 | 30 | 1414 | regulation of immune system process |
| GO:0007346 | 0.04499 | 1.74664 | 8 | 13 | 499 | regulation of mitotic cell cycle |
| GO:0051291 | 0.04515 | 2.40434 | 3 | 6 | 168 | protein heterooligomerization |
| GO:0033500 | 0.04518 | 2.08965 | 4 | 8 | 257 | carbohydrate homeostasis |
| GO:0002019 | 0.04526 | 32.22676 | 0 | 1 | 3 | regulation of renal output by angiotensin |
| GO:0002581 | 0.04526 | 32.22676 | 0 | 1 | 3 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II |
| GO:0002930 | 0.04526 | 32.22676 | 0 | 1 | 3 | trabecular meshwork development |
| GO:0003130 | 0.04526 | 32.22676 | 0 | 1 | 3 | BMP signaling pathway involved in heart induction |
| GO:0003133 | 0.04526 | 32.22676 | 0 | 1 | 3 | endodermal-mesodermal cell signaling |
| GO:0003134 | 0.04526 | 32.22676 | 0 | 1 | 3 | endodermal-mesodermal cell signaling involved in heart induction |
| GO:0003347 | 0.04526 | 32.22676 | 0 | 1 | 3 | epicardial cell to mesenchymal cell transition |
| GO:0006059 | 0.04526 | 32.22676 | 0 | 1 | 3 | hexitol metabolic process |
| GO:0006663 | 0.04526 | 32.22676 | 0 | 1 | 3 | platelet activating factor biosynthetic process |
| GO:0006858 | 0.04526 | 32.22676 | 0 | 1 | 3 | extracellular transport |
| GO:0007181 | 0.04526 | 32.22676 | 0 | 1 | 3 | transforming growth factor beta receptor complex assembly |
| GO:0010133 | 0.04526 | 32.22676 | 0 | 1 | 3 | proline catabolic process to glutamate |
| GO:0010159 | 0.04526 | 32.22676 | 0 | 1 | 3 | specification of animal organ position |
| GO:0010643 | 0.04526 | 32.22676 | 0 | 1 | 3 | cell communication by chemical coupling |
| GO:0010751 | 0.04526 | 32.22676 | 0 | 1 | 3 | negative regulation of nitric oxide mediated signal transduction |
| GO:0010901 | 0.04526 | 32.22676 | 0 | 1 | 3 | regulation of very-low-density lipoprotein particle remodeling |
| GO:0015684 | 0.04526 | 32.22676 | 0 | 1 | 3 | ferrous iron transport |
| GO:0019254 | 0.04526 | 32.22676 | 0 | 1 | 3 | carnitine metabolic process, CoA-linked |
| GO:0019405 | 0.04526 | 32.22676 | 0 | 1 | 3 | alditol catabolic process |
| GO:0021824 | 0.04526 | 32.22676 | 0 | 1 | 3 | cerebral cortex tangential migration using cell-axon interactions |
| GO:0021828 | 0.04526 | 32.22676 | 0 | 1 | 3 | gonadotrophin-releasing hormone neuronal migration to the hypothalamus |
| GO:0021856 | 0.04526 | 32.22676 | 0 | 1 | 3 | hypothalamic tangential migration using cell-axon interactions |
| GO:0023016 | 0.04526 | 32.22676 | 0 | 1 | 3 | signal transduction by trans-phosphorylation |
| GO:0030210 | 0.04526 | 32.22676 | 0 | 1 | 3 | heparin biosynthetic process |
| GO:0030421 | 0.04526 | 32.22676 | 0 | 1 | 3 | defecation |
| GO:0031120 | 0.04526 | 32.22676 | 0 | 1 | 3 | snRNA pseudouridine synthesis |
| GO:0032346 | 0.04526 | 32.22676 | 0 | 1 | 3 | positive regulation of aldosterone metabolic process |
| GO:0032349 | 0.04526 | 32.22676 | 0 | 1 | 3 | positive regulation of aldosterone biosynthetic process |
| GO:0034263 | 0.04526 | 32.22676 | 0 | 1 | 3 | positive regulation of autophagy in response to ER overload |
| GO:0034395 | 0.04526 | 32.22676 | 0 | 1 | 3 | regulation of transcription from RNA polymerase II promoter in response to iron |
| GO:0034499 | 0.04526 | 32.22676 | 0 | 1 | 3 | late endosome to Golgi transport |
| GO:0034633 | 0.04526 | 32.22676 | 0 | 1 | 3 | retinol transport |
| GO:0034769 | 0.04526 | 32.22676 | 0 | 1 | 3 | basement membrane disassembly |
| GO:0035283 | 0.04526 | 32.22676 | 0 | 1 | 3 | central nervous system segmentation |
| GO:0035284 | 0.04526 | 32.22676 | 0 | 1 | 3 | brain segmentation |
| GO:0035441 | 0.04526 | 32.22676 | 0 | 1 | 3 | cell migration involved in vasculogenesis |
| GO:0035793 | 0.04526 | 32.22676 | 0 | 1 | 3 | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway |
| GO:0035844 | 0.04526 | 32.22676 | 0 | 1 | 3 | cloaca development |
| GO:0035938 | 0.04526 | 32.22676 | 0 | 1 | 3 | estradiol secretion |
| GO:0036022 | 0.04526 | 32.22676 | 0 | 1 | 3 | limb joint morphogenesis |
| GO:0036023 | 0.04526 | 32.22676 | 0 | 1 | 3 | embryonic skeletal limb joint morphogenesis |
| GO:0036118 | 0.04526 | 32.22676 | 0 | 1 | 3 | hyaluranon cable assembly |
| GO:0036151 | 0.04526 | 32.22676 | 0 | 1 | 3 | phosphatidylcholine acyl-chain remodeling |
| GO:0038086 | 0.04526 | 32.22676 | 0 | 1 | 3 | VEGF-activated platelet-derived growth factor receptor signaling pathway |
| GO:0038091 | 0.04526 | 32.22676 | 0 | 1 | 3 | positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway |
| GO:0042360 | 0.04526 | 32.22676 | 0 | 1 | 3 | vitamin E metabolic process |
| GO:0045218 | 0.04526 | 32.22676 | 0 | 1 | 3 | zonula adherens maintenance |
| GO:0045329 | 0.04526 | 32.22676 | 0 | 1 | 3 | carnitine biosynthetic process |
| GO:0045918 | 0.04526 | 32.22676 | 0 | 1 | 3 | negative regulation of cytolysis |
| GO:0046864 | 0.04526 | 32.22676 | 0 | 1 | 3 | isoprenoid transport |
| GO:0046865 | 0.04526 | 32.22676 | 0 | 1 | 3 | terpenoid transport |
| GO:0048807 | 0.04526 | 32.22676 | 0 | 1 | 3 | female genitalia morphogenesis |
| GO:0051466 | 0.04526 | 32.22676 | 0 | 1 | 3 | positive regulation of corticotropin-releasing hormone secretion |
| GO:0055011 | 0.04526 | 32.22676 | 0 | 1 | 3 | atrial cardiac muscle cell differentiation |
| GO:0055014 | 0.04526 | 32.22676 | 0 | 1 | 3 | atrial cardiac muscle cell development |
| GO:0060671 | 0.04526 | 32.22676 | 0 | 1 | 3 | epithelial cell differentiation involved in embryonic placenta development |
| GO:0060672 | 0.04526 | 32.22676 | 0 | 1 | 3 | epithelial cell morphogenesis involved in placental branching |
| GO:0060720 | 0.04526 | 32.22676 | 0 | 1 | 3 | spongiotrophoblast cell proliferation |
| GO:0060722 | 0.04526 | 32.22676 | 0 | 1 | 3 | cell proliferation involved in embryonic placenta development |
| GO:0061182 | 0.04526 | 32.22676 | 0 | 1 | 3 | negative regulation of chondrocyte development |
| GO:0061502 | 0.04526 | 32.22676 | 0 | 1 | 3 | early endosome to recycling endosome transport |
| GO:0070368 | 0.04526 | 32.22676 | 0 | 1 | 3 | positive regulation of hepatocyte differentiation |
| GO:0071288 | 0.04526 | 32.22676 | 0 | 1 | 3 | cellular response to mercury ion |
| GO:0071603 | 0.04526 | 32.22676 | 0 | 1 | 3 | endothelial cell-cell adhesion |
| GO:0071798 | 0.04526 | 32.22676 | 0 | 1 | 3 | response to prostaglandin D |
| GO:0071799 | 0.04526 | 32.22676 | 0 | 1 | 3 | cellular response to prostaglandin D stimulus |
| GO:0071938 | 0.04526 | 32.22676 | 0 | 1 | 3 | vitamin A transport |
| GO:0071939 | 0.04526 | 32.22676 | 0 | 1 | 3 | vitamin A import |
| GO:0072138 | 0.04526 | 32.22676 | 0 | 1 | 3 | mesenchymal cell proliferation involved in ureteric bud development |
| GO:0072194 | 0.04526 | 32.22676 | 0 | 1 | 3 | kidney smooth muscle tissue development |
| GO:0072275 | 0.04526 | 32.22676 | 0 | 1 | 3 | metanephric glomerulus morphogenesis |
| GO:0072276 | 0.04526 | 32.22676 | 0 | 1 | 3 | metanephric glomerulus vasculature morphogenesis |
| GO:0072277 | 0.04526 | 32.22676 | 0 | 1 | 3 | metanephric glomerular capillary formation |
| GO:0072284 | 0.04526 | 32.22676 | 0 | 1 | 3 | metanephric S-shaped body morphogenesis |
| GO:0090327 | 0.04526 | 32.22676 | 0 | 1 | 3 | negative regulation of locomotion involved in locomotory behavior |
| GO:0097168 | 0.04526 | 32.22676 | 0 | 1 | 3 | mesenchymal stem cell proliferation |
| GO:0097374 | 0.04526 | 32.22676 | 0 | 1 | 3 | sensory neuron axon guidance |
| GO:0099152 | 0.04526 | 32.22676 | 0 | 1 | 3 | regulation of neurotransmitter receptor transport, endosome to postsynaptic membrane |
| GO:1900104 | 0.04526 | 32.22676 | 0 | 1 | 3 | regulation of hyaluranon cable assembly |
| GO:1900106 | 0.04526 | 32.22676 | 0 | 1 | 3 | positive regulation of hyaluranon cable assembly |
| GO:1900238 | 0.04526 | 32.22676 | 0 | 1 | 3 | regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway |
| GO:1900275 | 0.04526 | 32.22676 | 0 | 1 | 3 | negative regulation of phospholipase C activity |
| GO:1901963 | 0.04526 | 32.22676 | 0 | 1 | 3 | regulation of cell proliferation involved in outflow tract morphogenesis |
| GO:1902174 | 0.04526 | 32.22676 | 0 | 1 | 3 | positive regulation of keratinocyte apoptotic process |
| GO:1902606 | 0.04526 | 32.22676 | 0 | 1 | 3 | regulation of large conductance calcium-activated potassium channel activity |
| GO:1902608 | 0.04526 | 32.22676 | 0 | 1 | 3 | positive regulation of large conductance calcium-activated potassium channel activity |
| GO:1902722 | 0.04526 | 32.22676 | 0 | 1 | 3 | positive regulation of prolactin secretion |
| GO:1903237 | 0.04526 | 32.22676 | 0 | 1 | 3 | negative regulation of leukocyte tethering or rolling |
| GO:1903375 | 0.04526 | 32.22676 | 0 | 1 | 3 | facioacoustic ganglion development |
| GO:1904048 | 0.04526 | 32.22676 | 0 | 1 | 3 | regulation of spontaneous neurotransmitter secretion |
| GO:1904425 | 0.04526 | 32.22676 | 0 | 1 | 3 | negative regulation of GTP binding |
| GO:1905198 | 0.04526 | 32.22676 | 0 | 1 | 3 | manchette assembly |
| GO:1905292 | 0.04526 | 32.22676 | 0 | 1 | 3 | regulation of neural crest cell differentiation |
| GO:1905294 | 0.04526 | 32.22676 | 0 | 1 | 3 | positive regulation of neural crest cell differentiation |
| GO:1905310 | 0.04526 | 32.22676 | 0 | 1 | 3 | regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis |
| GO:1905312 | 0.04526 | 32.22676 | 0 | 1 | 3 | positive regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis |
| GO:2000137 | 0.04526 | 32.22676 | 0 | 1 | 3 | negative regulation of cell proliferation involved in heart morphogenesis |
| GO:2000312 | 0.04526 | 32.22676 | 0 | 1 | 3 | regulation of kainate selective glutamate receptor activity |
| GO:2000591 | 0.04526 | 32.22676 | 0 | 1 | 3 | positive regulation of metanephric mesenchymal cell migration |
| GO:2000611 | 0.04526 | 32.22676 | 0 | 1 | 3 | positive regulation of thyroid hormone generation |
| GO:2000721 | 0.04526 | 32.22676 | 0 | 1 | 3 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation |
| GO:2000864 | 0.04526 | 32.22676 | 0 | 1 | 3 | regulation of estradiol secretion |
| GO:2000983 | 0.04526 | 32.22676 | 0 | 1 | 3 | regulation of ATP citrate synthase activity |
| GO:2000984 | 0.04526 | 32.22676 | 0 | 1 | 3 | negative regulation of ATP citrate synthase activity |
| GO:2001027 | 0.04526 | 32.22676 | 0 | 1 | 3 | negative regulation of endothelial cell chemotaxis |
| GO:0006023 | 0.04541 | 3.96034 | 1 | 3 | 52 | aminoglycan biosynthetic process |
| GO:1901570 | 0.04541 | 3.96034 | 1 | 3 | 52 | fatty acid derivative biosynthetic process |
| GO:0015833 | 0.04581 | 1.38334 | 27 | 36 | 1757 | peptide transport |
| GO:0009161 | 0.04604 | 2.08120 | 4 | 8 | 258 | ribonucleoside monophosphate metabolic process |
| GO:0009199 | 0.04604 | 2.08120 | 4 | 8 | 258 | ribonucleoside triphosphate metabolic process |
| GO:0010469 | 0.04604 | 2.65763 | 2 | 5 | 127 | regulation of signaling receptor activity |
| GO:0032874 | 0.04624 | 2.38948 | 3 | 6 | 169 | positive regulation of stress-activated MAPK cascade |
| GO:0051149 | 0.04636 | 3.08428 | 1 | 4 | 88 | positive regulation of muscle cell differentiation |
| GO:0060998 | 0.04636 | 3.08428 | 1 | 4 | 88 | regulation of dendritic spine development |
| GO:0071774 | 0.04636 | 3.08428 | 1 | 4 | 88 | response to fibroblast growth factor |
| GO:0097061 | 0.04636 | 3.08428 | 1 | 4 | 88 | dendritic spine organization |
| GO:0055086 | 0.04661 | 1.66498 | 9 | 15 | 604 | nucleobase-containing small molecule metabolic process |
| GO:0001933 | 0.04665 | 1.83411 | 6 | 11 | 402 | negative regulation of protein phosphorylation |
| GO:0030031 | 0.04678 | 1.73569 | 8 | 13 | 502 | cell projection assembly |
| GO:0007610 | 0.04695 | 1.60813 | 11 | 17 | 709 | behavior |
| GO:0070304 | 0.04734 | 2.37481 | 3 | 6 | 170 | positive regulation of stress-activated protein kinase signaling cascade |
| GO:0030258 | 0.04737 | 2.19720 | 3 | 7 | 214 | lipid modification |
| GO:0031400 | 0.04743 | 1.69375 | 8 | 14 | 554 | negative regulation of protein modification process |
| GO:0010517 | 0.04760 | 3.88096 | 1 | 3 | 53 | regulation of phospholipase activity |
| GO:0030850 | 0.04760 | 3.88096 | 1 | 3 | 53 | prostate gland development |
| GO:0048247 | 0.04760 | 3.88096 | 1 | 3 | 53 | lymphocyte chemotaxis |
| GO:0002719 | 0.04791 | 6.15066 | 0 | 2 | 23 | negative regulation of cytokine production involved in immune response |
| GO:0008211 | 0.04791 | 6.15066 | 0 | 2 | 23 | glucocorticoid metabolic process |
| GO:0048485 | 0.04791 | 6.15066 | 0 | 2 | 23 | sympathetic nervous system development |
| GO:0050858 | 0.04791 | 6.15066 | 0 | 2 | 23 | negative regulation of antigen receptor-mediated signaling pathway |
| GO:0050995 | 0.04791 | 6.15066 | 0 | 2 | 23 | negative regulation of lipid catabolic process |
| GO:0070168 | 0.04791 | 6.15066 | 0 | 2 | 23 | negative regulation of biomineral tissue development |
| GO:0072202 | 0.04791 | 6.15066 | 0 | 2 | 23 | cell differentiation involved in metanephros development |
| GO:0072207 | 0.04791 | 6.15066 | 0 | 2 | 23 | metanephric epithelium development |
| GO:0140112 | 0.04791 | 6.15066 | 0 | 2 | 23 | extracellular vesicle biogenesis |
| GO:2000637 | 0.04791 | 6.15066 | 0 | 2 | 23 | positive regulation of gene silencing by miRNA |
| GO:2000831 | 0.04791 | 6.15066 | 0 | 2 | 23 | regulation of steroid hormone secretion |
| GO:0001938 | 0.04798 | 3.04786 | 1 | 4 | 89 | positive regulation of endothelial cell proliferation |
| GO:0009063 | 0.04798 | 3.04786 | 1 | 4 | 89 | cellular amino acid catabolic process |
| GO:0051937 | 0.04798 | 3.04786 | 1 | 4 | 89 | catecholamine transport |
| GO:0060415 | 0.04798 | 3.04786 | 1 | 4 | 89 | muscle tissue morphogenesis |
| GO:0050767 | 0.04803 | 1.52410 | 14 | 21 | 925 | regulation of neurogenesis |
| GO:0031346 | 0.04824 | 1.77110 | 7 | 12 | 454 | positive regulation of cell projection organization |
| GO:0010977 | 0.04846 | 2.36031 | 3 | 6 | 171 | negative regulation of neuron projection development |
| GO:0007189 | 0.04866 | 2.61453 | 2 | 5 | 129 | adenylate cyclase-activating G protein-coupled receptor signaling pathway |
| GO:0007605 | 0.04866 | 2.05624 | 4 | 8 | 261 | sensory perception of sound |
| GO:0051924 | 0.04866 | 2.05624 | 4 | 8 | 261 | regulation of calcium ion transport |
| GO:0006816 | 0.04872 | 1.81990 | 6 | 11 | 405 | calcium ion transport |
| GO:0009260 | 0.04935 | 2.17598 | 3 | 7 | 216 | ribonucleotide biosynthetic process |
| GO:0071241 | 0.04935 | 2.17598 | 3 | 7 | 216 | cellular response to inorganic substance |
| GO:0060560 | 0.04956 | 2.04806 | 4 | 8 | 262 | developmental growth involved in morphogenesis |
| GO:0006119 | 0.04963 | 3.01229 | 1 | 4 | 90 | oxidative phosphorylation |
| GO:0030199 | 0.04985 | 3.80470 | 1 | 3 | 54 | collagen fibril organization |
| GO:0035272 | 0.04985 | 3.80470 | 1 | 3 | 54 | exocrine system development |
| GO:0055025 | 0.04985 | 3.80470 | 1 | 3 | 54 | positive regulation of cardiac muscle tissue development |